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With the increasing adoption of health information technology and the growth in the 
resulting electronic repositories of clinical data, the secondary use of electronic health record data 
has become one of the most promising approaches to enabling and speeding clinical research. 
Unfortunately, electronic health record data are known to suffer from significant data quality 
problems. Awareness of the problem of electronic health record data quality is growing, but 
methods for measuring data quality remain ad hoc. Clinical researchers must handle this 
complicated problem without systematic or validated methods. The lack of appropriate or 
trustworthy electronic health record data quality assessment methodology limits the validity of 
research performed with electronic health record data.  
This dissertation documents the development of a data quality assessment framework and 
guideline for clinical researchers engaged in the secondary use of electronic health record data for 
retrospective research. Through a systematic literature review and interviews with key 
stakeholders, we identified core constructs of data quality, as well as priorities for future 
approaches to electronic health record data quality assessment. We used a data-driven approach to 
demonstrate that data quality is task-dependent, indicating that appropriate data quality measures 
must be selected, applied, and interpreted within the context of a specific study. On the basis of 
these results, we developed and evaluated a dynamic guideline for data quality measures in order 
to help researchers choose data quality measures and methods appropriately within the context of 
reusing electronic health record data for research.  
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  Chapter 2: State of the Field 
Chapter 1: Enabling the Reuse of Electronic 
Health Record Data through Data Quality 
Assessment and Transparency:  
An Overview 
1.1 Introduction 
With the increasing adoption of health information technology and the growth in the 
resulting electronic repositories of clinical data, the secondary use of electronic health record 
(EHR) data has become one of the most promising approaches to enabling and speeding clinical 
research. Unfortunately, EHR data are known to suffer from significant data quality problems 
exceeding those associated with data collected in traditional research settings. Awareness of the 
problem of EHR data quality is growing, but available methods for measuring data quality remain 
ad hoc. Clinical researchers are left to handle this complicated problem without systematic or 
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validated methods. The lack of appropriate or trustworthy EHR data quality assessment 
methodology limits the efficiency and validity of research performed with EHR data.  
This dissertation documents the development of a data quality assessment framework and 
associated guidelines targeted at clinical researchers engaged in the secondary use of EHR data 
for retrospective research. Through a systematic literature review and interviews with key 
stakeholders, we identified core constructs of data quality relevant to the secondary use of EHR 
data, as well as priorities for future approaches to EHR data quality assessment. We used a data-
driven approach to demonstrate that data quality is task-dependent, indicating that appropriate 
data quality measures must be selected, applied, and interpreted within the context of a specific 
study. On the basis of these results, we developed and evaluated a dynamic guideline for data 
quality measures in order to help researchers choose data quality measures and methods 
appropriately within the context of reusing EHR data for research.  
1.2 Background 
1.2.1 The Promise of EHR Data Secondary Use 
The past few decades have seen growing adoption of electronic health records. Since the 
enactment of the Health Information Technology for Economic and Clinical Health (HITECH) 
Act in 2009, which includes incentives and penalties encouraging the adoption and meaningful 
use of EHRs,(1, 2) there has been an increase in the rate of EHR adoption. As of 2012, the rate of 
adoption of EHRs with at least basic functionality was 44.4% in non-federal acute care 
hospitals(3) and 39.6% in office-based physician practices.(4) Other estimates have placed rates 
of adoption amongst family physicians at 68% as of 2011.(5) The ubiquity of EHRs makes the 
secondary use of data collected during the course of clinical care  a promising step towards 
decreasing research costs, increasing patient-centered research, and speeding the rate of medical 
discovery. Therefore, as the adoption of EHRs has made it easier to access and aggregate clinical 
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data, there has been growing interest among clinicians, researchers, and funding and regulatory 
agencies in conducting research with EHR data.(6-8)  
The transition from paper records to EHRs has resulted in large repositories of 
computerized data, simplifying the process of reusing data recorded during the course of clinical 
care. The reuse of these data may diminish the costs and inefficiencies associated with clinical 
research. Many of the common processes involved in standard approaches to research, including 
participant recruitment and retention and the gathering of data, are expensive and time-
consuming.(9) The identification and inclusion of certain populations in clinical research can be 
especially challenging. Overcoming the underrepresentation of ethnic minorities in research, for 
example, requires significant attention and effort.(10) Like other forms of retrospective research, 
studies that make use of EHR data do not require patient recruitment or data collection, 
eliminating much of the time and expense involved in prospective research. And, with the 
exception of large-scale research projects like the Framingham Heart Study and WICER, EHR 
data repositories contain more data than are collected for prospective studies, including more 
variables, longer periods of time, and greater numbers of patients.  
The secondary use of EHR data may also address one of the primary limitations of 
randomized controlled trials: limited external validity.(11) The data from EHRs offer a window 
into the medical care, status, and outcomes of a diverse population that is representative of actual 
patients. This makes EHR data reuse particularly valuable for Comparative Effectiveness 
Research (CER)(12) and Patient Centered Outcomes Research (PCOR)(13) in their potential to 
enable comparisons of therapies that are meaningful for patients. As part of the American 
Recovery and Reinvestment Act of 2009, $1.1 billion were made available for CER.(14) The 
following year, the Patient Protection and Affordable Care Act established the PCOR Institute, 
which is dedicated to the guidance and funding of CER and PCOR.(15) It is clear that clinical 
research focusing on real life patient care and outcomes is currently a national priority, and EHR-
derived datasets are ideally suited for such research.(16) Overall, the reuse of EHR data for 
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clinical research has the promise to bring us closer to a learning healthcare system, in which the 
generation of new medical knowledge and best practices arise naturally from the standard patient 
care process.(17) 
1.2.2 EHR Data Quality 
Despite these benefits, the reuse of EHR data has been limited by a number of factors, 
including concerns about the quality of the data and their suitability for research.(18, 19)  It is 
generally accepted that clinical data are not recorded with the same care as research data.(20) 
Research data are often obtained and recorded under controlled conditions with carefully 
maintained workflows. The collection of high quality data is a primary focus in the traditional 
research approach. Data collected during the course of standard care, however, are in many ways 
a byproduct of the healthcare system. Clinical information is measured and recorded primarily to 
fulfill documentation requirements for patient care and administrative purposes. Moreover, it has 
been said that the adoption of health information technology like EHRs has led not to 
improvements in the quality of the data being recorded, but rather to the recording of a greater 
quantity of poor quality data.(21) Due in large part to concerns about DQ, van der Lei warned 
specifically against the reuse of clinical data for research and proposed what he called the first 
law of informatics: “[d]ata shall be used only for the purpose for which they were collected.”(22) 
Although such concerns about data quality have existed since EHRs were first 
introduced, there remains no consensus as to the quality of electronic clinical data and its 
suitability for retrospective research. In fact, the quality of clinical data has been shown to be not 
only poor, but highly variable. Multiple studies have demonstrated that it is not possible to 
generalize data quality findings. Hogan and Wagner, in their 1997 literature review, found that 
the correctness of data ranged between 44% and 100%, and completeness between 1.1% and 
100%, depending upon the clinical concepts being studied.(23) Similarly, Thiru et al., in 
calculating the sensitivity of different types of EHR data in the literature, found values ranging 
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between 0.26 and 1.00.(24) In a 2010 review, Chan et al. looked at the quality of the same clinical 
concepts across multiple institutions, and still found a great deal of variability. The completeness 
of blood pressure recordings, for example, fell anywhere between 0.1% and 51%.(25)  
This variability in quality is due in part to differences in measurement, recording, 
information systems, clinical workflows, and clinical focus. Data quality variations can also be 
explained, however, by the concept of “fitness for use,” which was first proposed by J. M. 
Juran.(26) Within the context of data quality and EHR data reuse, this means that an EHR-
derived dataset is of sufficient quality when it allows a researcher to perform a study of interest 
and achieve results that are not invalidated by data quality problems. According to this definition, 
data quality is task-dependent, meaning that it is generally inadvisable to make assumptions about 
one EHR-derived dataset based upon another. Therefore, clinical researchers engaged in the 
secondary use of EHR data need systematic methods that will allow them to assess the quality of 
an EHR-derived dataset for a given research task. 
1.3 Related Work 
An ideal knowledge-based guideline for EHR data quality assessment should be all of the 
following: comprehensive, systematic, and dynamic. To be comprehensive it must include the 
major categories of data quality (e.g. correctness) that are relevant to the secondary use of EHR 
data. A systematic guideline would describe concrete, evidence-based, and, where possible, 
validated methods of assessing data quality. Finally, the guideline must be flexible in order to 
allow for fitness-for-use: different use cases will require different approaches to data quality 
assessment. Chapter 2 of this dissertation presents a thorough review of data quality categories 
and assessment methods from the informatics literature. A brief exploration of foundational work 
on data quality from informatics and related fields is included below. 
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1.3.1 Terminologies and Models for Data Quality Assessment 
One of the most influential works on data quality is the industry model initially published 
by Wang and Strong in 1996.(27) Wang and Strong were heavily influenced by the concept 
“fitness for use,” and were some of the first researchers to apply this definition of quality to data 
and databases from the data consumer viewpoint. Using a combination of literature review, user 
surveys, and user-based sorting tasks, Wang and Strong identified fifteen dimensions of data 
quality. The fifteen dimensions are organized in a hierarchy containing four primary categories, 
as shown in Figure 1.  
 
Figure 1.1 Wang and Strong's data quality model. 
More recently, there have been increasing efforts to develop models of data quality 
specifically for EHRs. Liaw et al. performed a review of publications that used ontological 
approaches to data quality within the context of “routine data” use for chronic disease 
management, and found that the five most commonly included dimensions of data quality were 
accuracy, completeness, consistency, correctness, and timeliness.(28)  A validated, 
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1.3.2 Data Quality Assessment Approaches 
A number of fields, particularly business, management, accounting, and information 
technology, have produced systematic approaches to data quality assessment. To understand the 
relevance of these approaches, however, it is important to understand what is meant by data 
quality assessment methods. “Methods” is meant to imply approaches for actually measuring data 
quality, which are rarely described in existing approaches. 
Some approaches to data quality assessment, for example, present data quality metrics, 
rather than methods, where a metric is a system of measurement. Metrics are valuable because 
they allow standardized reporting and comparisons between results. They do not, however, give 
users direction on how to actually assess data quality in the first place. Hogan and Wagner, for 
example, present metrics for data completeness and correctness, but assume that a reference 
standard is available in order to calculate positive predictive value and sensitivity.(23) Pipino et 
al., in their heavily cited article on data quality assessment, describe three functional forms for 
reporting on data quality: ratios of problem elements to all elements, min or max reporting of data 
quality indicators, and weighted averages when there are multiple variables of interest.(29) 
Underlying all of these forms, however, is the assumption that users already have methods 
available to make subjective or objective assessments of data quality. 
In other cases, data quality assessment refers to review of the processes surrounding data 
collection, storage, and governance, rather than methods that can be used to measure the quality 
of the data themselves. The International Monetary Fund Data Quality Assessment Framework, 
for example, essentially says that data are of good quality if regular steps are taken to ensure good 
data practices.(30) Similarly, Wang and Strong’s fifteen dimensions of data quality, described 
above, include concepts related to data representation and accessibility issues, which are not 
related to inherent issues of data quality.(27) In describing his model of data quality and data 
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error propagation, Ballou specifically stated that his work was process-oriented, rather than data-
oriented.(31) 
There are, however, a few existing methodological approaches to EHR data quality 
assessment. Falconer et al. proposed an eight-step process for examining the quality of diagnostic 
data that includes assessments of prevalence, completeness, accuracy, currency, consistency, 
sensitivity, and positive predictive value.(32) More recently, Kahn et al. developed a conceptual 
model for data quality assessment based upon fitness-for-use. The model incorporates a number 
of data quality categories from Wang and Strong’s model, including accuracy, objectivity, 
believability, timeliness, and appropriate amount of data.(33) The Observational Medical 
Outcomes Partnership (OMOP), has developed automated data quality assessment “toolkits,” 
called OSCAR and GROUCH, which can be used to measure, amongst other data quality 
dimensions, completeness, accuracy, and timeliness. These toolkits, however, are limited to use 
with the OMOP data model.(34) 
EHR data quality assessment requires systematic approaches that allow the user to assess 
data quality without detailed knowledge of the processes that produced these data in the first 
place. Similarly, although standardized metrics are valuable for reporting, methods that give 
guidance on how to make measurements of data quality must be an area of focus. Overall, what is 
currently needed in order to enable secondary use of EHR data is a knowledge-based approach to 
EHR data quality assessment methods that can be applied systematically, though in a task-
dependent manner. 
1.4 Approach 
1.4.1 Summary of Approach 
This dissertation describes a mixed methods approach to the development and evaluation 
of a guideline for EHR data quality assessment within the context of secondary use. Our goal was 
to use knowledge- and data-driven approaches to combine the relevant categories of data quality 
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and proven methods of data quality assessment and present them in a way that considered user 
needs and perceptions. The studies described in Aims I, II, and III contributed necessary 
components and conceptual approaches to the guideline described in Aim V (Figure 2). 
 
Figure 1.2 Dissertation flowchart. 
 
Aim I: Identify the most commonly assessed categories of data quality and the most commonly 
used assessment methods in the secondary use of EHR data.  
Aim II: Identify clinical researchers’ attitudes toward and perceptions of EHR data quality as it 
relates to the secondary use of EHR. 
Aim III: Determine if and how fitness-for-use applies to EHR data quality within the context of 
secondary use 
Aim IV: Explore the relationship between patient health, data sufficiency, and the potential for 
sampling bias in the secondary use of EHR data. 
Aim V: Develop and evaluate a data quality assessment guideline for clinical researchers engaged 
in the secondary use of EHR data. 
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1.4.2 Aim I: The state of the EHR data quality assessment field 
Objective: Identify the most important categories of data quality and the most common data 
quality assessment methods from the informatics literature describing the secondary use of EHR 
data. Determine which methods are best suited to which categories. 
Hypothesis: Different EHR data quality assessment methods are most commonly used for specific 
EHR data quality categories.  
Research Questions: 
• What categories of data quality are important to the secondary use of EHR data? 
• What are common methods for EHR data quality assessment? 
• Which methods are used for which categories? 
• What are the current gaps in knowledge in the area of EHR data quality assessment? 
Methods and Materials: 
The primary methodology of this aim was a systematic literature review. The review 
focused on peer-reviewed articles describing original research that included a) secondary use of 
EHR data and b) data quality assessment. A two stage process was used to identify articles. First, 
a search was performed using PubMed’s search feature and relevant MeSH headings. This search 
produced 230 results, which were then winnowed down to 44 relevant articles. Next, an ancestor 
search was used to find another 51 articles that were not identified during the initial search. 
Two primary types of information were extracted from each of the 95 articles in the final 
sample: the features of data quality that were assessed, and the methods of assessment that were 
used. An iterative approach was used to group the data quality categories and methods into 
meaningful themes. Finally, the derived data quality methods and categories were applied to each 
of the 95 articles, which allowed us to determine how frequently each method was used to assess 
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From the final pool of 95 articles, we identified five categories of EHR data quality and 
seven general approaches to EHR data quality assessment. . The data quality categories were 
derived from 27 unique data quality terms, and are as shown in Table 1. 
 
Table 1.1 Categories of EHR data quality. 
Data Quality Category Definition 
Completeness Is a truth about a patient present in the EHR? 
Correctness Is an element that is present in the EHR true? 
Concordance Is there agreement between elements in the EHR, or between the EHR 
and another data source? 
Plausibility Does an element in the EHR makes sense in light of other knowledge 
about what that element is measuring? 
Currency Is an element in the EHR a relevant representation of the patient state at 
a given point in time? 
 
The seven categories of data quality assessment approaches are detailed below in 
descending order of frequency use. . Most of the 95 articles did not explicitly label the approach 
used. Instead, these categories were derived from occasionally vague methodological 
descriptions. 
 
Table 1.2 Categories of EHR data quality assessment approaches. 
Data Quality Category Definition 
Gold standard A dataset drawn from another source or multiple sources, with or 
without information from the EHR, is used as a gold standard. 
Data element 
agreement 
Two or more elements within an EHR are compared to see if they report 
the same or compatible information. 
Element presence A determination is made as to whether or not desired or expected data 
elements are present. 
Data source agreement Data from the EHR are compared to data from another source to 
determine if they are in agreement. 
Distribution 
comparison 
Distributions or summary statistics of aggregated data from the EHR 
are compared to the expected distributions for the clinical concepts of 
interest. 
Validity check Data in the EHR are assessed using various techniques that determine if 
values “make sense.” 
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Certain methodological approaches are used more frequently for certain data quality 
categories. For example, gold standard-based assessment is the most commonly used approach 
for assessing correctness, while currency is assessed solely through the review of log data. . A 
complete mapping between the data quality categories and methodological approaches is shown 
in Figure 3. 
The findings from the literature review indicate a few problems with current approaches 
to EHR data quality assessment within the context of secondary use. . First, the majority of 
researchers currently use ad hoc approaches, which limits the comparability and validity of data 
quality findings. . The lack of existing systematic approaches also increases the burden being put 
upon researchers who wish to use EHR data. . Second, there is currently an overreliance upon the 
use of gold standards for EHR data quality assessment. . This was by far the most common 
assessment approach in the articles included in the review. . In many—if not most—cases gold 
standards are not available, which means that this is not a generalizable approach. 
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1.4.3 Aim II: Clinical researcher attitudes and perceptions 
regarding EHR data quality 
Objective: Gain an understanding of the factors that make clinical researchers more or less likely 
to engage in the secondary use of EHR data, especially as related to issues of data quality. 
Hypothesis: Researcher awareness of and concerns about EHR data quality are a rate-limiting 
factor in the secondary use of EHR data. 
Research Questions: 
• How do clinical researchers define data quality? 
• What do clinical researchers think about the quality of EHR data, specifically in the 
context of research? 
• What factors make clinical researchers more or less likely to engage in the secondary use 
of EHR data? 
• What sorts of research do clinical researchers prefer to perform with EHR data? 
Methods and Materials: 
Aim II relied upon a qualitative approach in order to develop an understanding of how 
clinical researchers view EHR data as a resource for secondary use. A series of ten unstructured 
interviews were conducted with clinical researchers in the Columbia University Medical Center 
community. Three broad categories of discussion were identified for the interviews: experience 
using EHR data for clinical research, perceptions of EHR data quality, and intent to use EHR data 
for research going forward. The interview guide was designed to explore researchers’ actual 
experiences wherever possible, rather than hypotheticals. Following the interviews, the digital 
recordings were de-identified, transcribed, and then analyzed. 
The interview data were analyzed using content analysis and a combined inductive-
deductive approach. The inductive analysis was based upon the Precede-Proceed Model (shown 
in Figure 3), specifically the third phase of the model, which focuses on identifying factors that 
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make the target population (clinical researchers, in our scenario) more or less likely to engage in 
the desired behavior (the secondary use of EHR data).(35) The trustworthiness of the findings 
was ensured through two methods. Member checks were employed during the interviews and 
following analysis.(36, 37) An audit trail was also maintained over the course of the interviews 
and analysis and then reviewed by an expert in qualitative research.(36, 38, 39) 
 
 
Figure 1.4 Precede-Proceed Model. 
Primary Findings: 
We identified seven categories of data quality that the participants believed were relevant 
to the secondary use of EHR data: completeness, correctness, fragmentation, granularity, 
concordance, structured, and signal-to-noise. . Three of these (completeness, correctness, and 
concordance) overlap with the five categories identified in the literature review described in Aim 
I (Chapter 2).  
We also discovered that although the majority of the participants were aware of EHR data 
quality limitations and had conflicting or negative attitudes toward the secondary use of EHR 
data, they intended to begin or continue conducting research with EHR data. . For the most part, 
the perceived benefits and opportunities associated with the secondary use of EHR data 
outweighed their concerns about the limited validity of research conducted with these data. . This 
14 
 
  Chapter 2: State of the Field 
finding drives home the importance of developing and disseminating systematic, valid, and 
feasible approaches to EHR data quality assessment. 
Lastly, the participants emphasized the importance of involved domain experts and 
clinicians in the secondary use of EHR data. . Clinicians with experience using the EHR systems 
from which the data are extracted are uniquely suited to understanding the peculiarities and 
limitations of these data. . Therefore, the participant felt that data extraction, validation, and 
analysis should all be informed by individuals who are familiar with the data and data collection 
processes. 
1.4.4 Aim III: The task-dependence of EHR data quality  
Objective: Determine if the concept of fitness for use applies to EHR data quality within the 
context of secondary use. 
Hypothesis: The use scenario for an EHR-derived dataset determines how data quality will be 
addressed, which in turn affects data quality findings. 
Research Questions: 
• Is EHR data quality task-dependent? 
• How complete are EHR data? 
• How do definitions and operationalizations of data quality concepts impact data quality 
findings? 
Methods and Materials: 
Aim III uses a data-driven approach to explore the concepts of EHR data completeness 
and fitness for use. Completeness was selected from the data quality categories described in Aims 
I and II because it is frequently described as being context-dependent.(27, 33) Four different 
operationalizations of EHR data completeness and associated methods of assessment were 
identified from the literature. The operationalizations were defined as follows: 
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Table 1.3 Operational definitions of EHR data completeness. 
Operationalization Definition 
Documentation A record contains all observations made about a patient. 
Breadth A record contains all desired types of data. 
Density A record contains a specified number or frequency of data points over 
time. 
Predictive A record contains sufficient information to predict a phenomenon of 
interest. 
 
Each operationalization was tested against a dataset consisting of representative, 
frequently used types of data from the Columbia University Medical Center clinical data 
warehouse. These data included diagnoses, medication orders, laboratory results, visit 
information, and demographic information. Data from approximately 3.9 million unique patients 
records were used. Each operationalization was tested individually and plotted along increasing 
thresholds of completeness (i.e. fit for use). Simple versions of all four definitions were also 
tested against the data simultaneously to allow direct comparisons of which records were 
considered complete according to each definition. 
Primary Findings: 
The most basic take-home from this aim is that there are significant and unexpected 
limitations to the completeness of even the most basic EHR data elements. This was true for all 
four operational definitions. . Even with the most lenient cut-offs (i.e. at least one data point with 
the associated data of interest), only about half or fewer of the patient records can be considered 
complete according to the breadth, density, or documentation definitions.. . With more stringent 
cut-offs, where more data points are desired, these proportions drop precipitously. . Therefore, it 
is clear that EHR data completeness assessment should be a priority in the secondary use of EHR 
data. 
Further complicating this issue is the fact that records that are complete according to one 
operational definition are not necessarily complete according to another. This is illustrated by 
Figure 4, which presents a visual comparison of the records deemed complete according to 
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illustrative examples of each of the four definitions. These results indicate that data completeness 
is dependent upon the use scenario and how completeness is operationalized, and that data quality 
assessment must be dynamic in order to capture task-dependence. 
1.4.5 Aim IV: Sufficient EHR data quality and sampling bias 
Objective: Explore the relationship between variation in data completeness and the potential for 
sampling bias in the secondary use of EHR data. 
Hypothesis: Sicker patients have more complete records. 
Research Questions: 
• Is the quantity of data contained in a patient record random, or is it correlated with 
underlying patient health status? 
• Is variation in EHR data quality a potential source of sampling bias? 
Methods and Materials: 
After uncovering extensive variation in EHR data completeness in Aim III, we wanted to 
further explore the issue of completeness and its possible determinants. Specifically, we 
hypothesized that completeness might be linked to patient health. To determine if this was the 
case, we needed to identify a variable to represent overall health, as well as a metric of 
completeness. We selected the American Society of Anesthesiologists (ASA) Physical Status 
Classification System as our health indicator, and conceptualized record completeness as counts 
of days with medication orders and days with laboratory results. A non-parametric test was used 
to test the relationship between patient health and record completeness. 
Primary Findings:  
On average, patients with a more severe health status have a higher number of days with 
medication orders and a higher number of days with laboratory results. A Kruskal-Wallice one-
way analysis of variance revealed a significant effect of ASA Class on number of days with 
medication orders (x2(3)=332.0, p<0.0001) and on number of days with laboratory results 
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(x2(3)=202.2, p<0.0001). Post-hoc analyses using a Bonferonni correct Wilcoxon rank sum test 
showed significant differences between all ASA Classes except Class 1 and Class 2 for both 
variables. Figure 5 shows the average number of days with data broken down by ASA class for 
both medication orders and laboratory results.  
 
Figure 1.5 Average number of days with data per patient by ASA class. 
 
These findings indicate two potential dangers to the secondary use of EHR data. First, a 
sample of patients drawn naively from the EHR-- assuming the records chosen are limited to 
those with sufficient data for the task at hand-- may be biased towards sicker patients. Second, 
researchers who wish to identify healthy controls for a study may have difficulty identifying 
patients with sufficient data. In both cases, the external validity of research conduct with EHR 
data may be compromised. 
1.4.6 Aim V: Development and evaluation of EHR data quality 
assessment guideline 
Objective: Use an iterative approach to the development of an EHR data quality assessment 
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Methods and Materials: 
The goal of this aim was to develop a data quality assessment framework and associated 
guidelines that took into account the findings of Aims I, II, and III. Specifically, the framework 
would combine the categories of data quality identified in Aims I and II and the methods of data 
quality assessment from Aim I and non-informatics literature. The concept of fitness for use, 
which was demonstrated in Aim III, also needed to be considered in the development process. 
The framework needed to be dynamic, since different secondary use scenarios would have 
different data requirements, and the determination of “sufficient” data quality had to be flexible. 
Finally, the framework and guideline were designed to allow users to bring their own expertise to 
bear on the data quality assessment process, as indicated by the results of Aim III. 
The development of the framework and guidelines took place in two cycles. The initial 
development was followed by evaluation by content experts. Another round of development 
followed, as dictated by the experts’ feedback. The evaluation used a basic psychometric 
approach, in which experts in the area of EHR data quality were asked to evaluate the framework 
and guidelines in terms of comprehensiveness, validity, clarity, and feasibility. Forced binary 
responses were used. 
Primary Findings: 
The resulting guideline is called 3x3 DQA, which refers to data quality assessment 
performed for three data quality constructs (correct, complete, current) across three data 
dimensions (patients, variables, time).  The data quality constructs were selected and defined 
based upon the results from Aims I and II, and the data dimensions are taken from the basic 
dimensions of data flat files and data cubes.  The full document is 26 pages long, and is divided 
into six primary sections: introduction, user guide, questions to determine the scope of the 
assessment, framework, assessment and reporting recommendations, and references.  The 
framework, which is at the heart of the guideline and operationalizes each of the quality 
constructs across the data dimensions, is shown in Figure 5. 
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Figure 1.6 3x3 DQA framework. 
 
The recommendations, which give actionable, knowledge- and evidence-based 
suggestions on how to measure and report data quality for each of the nine operationalizations in 
the framework, are divided into four parts.  These include how to perform the measurement, how 
to report the findings, a simple example, and a list of relevant references.  One of the two 
recommendations for assessing if data are correct across patients is shown in Figure 6. 
The initial expert-based evaluation of 3x3 DQA included five participants. It is clear from 
the responses that certain aspects of the guideline require significant work. Although the 
participants liked the overall framework and approach, the wording of the constructs and 
operationalizations were subject to criticism regarding clarity and validity. Data quality 
assessment is an area in which clarity of meaning and intent is especially important. Responses to 
the recommendations were more positive, overall, though respondents requested further 
clarification regarding the role of the user. Specifically, there was concern about the frequency 
with which the user was asked to make judgments regarding which data were desired and how 
many data were sufficient. Some of the recommendations also require significant external 
knowledge, which was a cause of concern for some of the respondents. 
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Figure 1.7 One of two recommendations for data correctness across the patient dimension. 
 
1.5 Contributions 
The contributions of this dissertation fall into two categories. The most obvious—and 
primary—contribution of this dissertation is the initial iteration of 3x3 DQA, a guideline intended 
to assist clinical researchers in the assessment and reporting of EHR data quality within the 
context of secondary use. This guideline includes a framework and associated recommendations 
for data quality measurement and reporting, as well as a set of questions to help users determine 
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which elements are relevant for a given research task. While 3x3 DQA is not yet ready for 
dissemination, it has been well-received by evaluators, and is a promising step towards 
systematic, transparent, and evidence-based EHR data quality assessment. 
The primary findings of each of the aims that led to the development of 3x3 DQA 
represent a set of “best practices” for EHR data quality assessment that can be used to direct 
informatics research independent from the guideline.  These best practices include: literature-
derived and user-derived sets of data quality categories that should be considered; knowledge-
based and evidence-based data quality assessment methods that can be used; a need for a task-
dependent approach that embraces fitness-for-use; the link between data quality and potential 
sampling bias in cohort selection; and the inclusion of user knowledge and user decision-making 
in the data quality assessment process (as opposed to a fully automated black-box approach). 
1.6 Guide for the reader 
Chapter 2 is an in-depth review of the literature on EHR data quality assessment within the 
context of secondary use. . I identified categories of data quality, methods of EHR data 
quality assessment, and several of the existing knowledge gaps in the current approaches 
to EHR data quality assessment. 
Chapter 3 describes a qualitative study in which clinical researchers were asked about their 
experiences, beliefs, attitudes, and intentions as they relate to the secondary use of EHR 
data and EHR data quality. 
Chapter 4 reports on a study of the completeness of EHR data, where completeness is 
operationalized for four different potential use cases. . This study demonstrates that EHR 
data quality is task-dependent. 
Chapter 5 presents a follow-up study in which the relationship between completeness and 
underlying patient health status is explored, and demonstrates that selecting for patients 
with high quality EHR data may inadvertently bias samples towards sicker patients. 
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Chapter 6 details the development and evaluation of an EHR data quality assessment guideline. 
Chapter 7 summarizes the contributions of the research described in this dissertation, as well as 
what I see as the next steps in EHR data quality assessment research and related areas of 
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Chapter 2: The State of the Electronic 
Health Record Data Quality  
Assessment Field1 
2.1 Introduction 
As the adoption of electronic health records (EHR) has made it easier to access and 
aggregate clinical data, there has been growing interest in conducting research with data collected 
during the course of clinical care.(1, 2)  The NIH has called for increasing the reuse of electronic 
records for research, and the clinical research community has been actively seeking methods to 
enable secondary use of clinical data.(3) EHRs surpass many existing registries and data 
repositories in volume, and the reuse of these data may diminish the costs and inefficiencies 
associated with clinical research.  Like other forms of retrospective research, studies that make 
1 This chapter was originally published in the Journal of the American Medical Informatics Association. 
The full citation for this publication is: Weiskopf NG, Weng C. Methods and dimensions of electronic 
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use of EHR data do not require patient recruitment or data collection, both of which are expensive 
and time-consuming processes.  The data from EHRs also offer a window into the medical care, 
status, and outcomes of a diverse population that is representative of actual patients.  The 
secondary use of data collected in EHRs is a promising step towards decreasing research costs, 
increasing patient-centered research, and speeding the rate of new medical discoveries.   
Despite these benefits, reuse of EHR data has been limited by a number of factors, 
including concerns about the quality of the data and their suitability for research.  It is generally 
accepted that, as a result of differences in priorities between clinical and research settings, clinical 
data are not recorded with the same care as research data.(4) Moreover, Burnum stated that the 
introduction of health information technology like EHRs has led not to improvements in the 
quality of the data being recorded, but rather to the recording of a greater quantity of bad data.(5) 
Due to such concerns about data quality, van der Lei warned specifically against the reuse of 
clinical data for research and proposed what he called the first law of informatics: “[d]ata shall be 
used only for the purpose for which they were collected.”(6)  
Although such concerns about data quality have existed since EHRs were first 
introduced, there remains no consensus as to the quality of electronic clinical data or even 
agreement as to what “data quality” actually means in the context of EHRs.  One of the most 
broadly adopted conceptualizations of quality comes from Juran, who said that quality is defined 
through “fitness for use.”(7)  In the context of data quality, this means that data are of sufficient 
quality when they serve the needs of a given user pursuing specific goals.  
Past study of EHR data quality has revealed highly variable results.  Hogan and Wagner, 
in their 1997 literature review, found that the correctness of data ranged between 44% and 100%, 
and completeness between 1.1% and 100%, depending upon the clinical concepts being 
studied.(8)  Similarly, Thiru et al., in calculating the sensitivity of different types of EHR data in 
the literature, found values ranging between 0.26 and 1.00.(9)  In a 2010 review, Chan et al. 
looked at the quality of the same clinical concepts across multiple institutions, and still found a 
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great deal of variability.  The completeness of blood pressure recordings, for example, fell 
anywhere between 0.1% and 51%.(10) Due to differences in measurement, recording, 
information systems, and clinical focus, the quality of EHR data is highly variable.  Therefore, it 
is generally inadvisable to make assumptions about one EHR-derived dataset based on another.  
We need systematic methods that will allow us to assess the quality of an EHR-derived dataset 
for a given research task.   
Our review primarily differs from those highlighted above in its focus.  The previous 
reviews looked at data quality findings, while ours instead focuses on the methods that have been 
used to assess data quality.  In fact, the earlier reviews were explicitly limited to studies that 
relied upon the use of a reference standard, while we instead explore a range of data quality 
assessment methods.  The contributions of this literature review are an empirically based 
conceptual model of the dimensions of EHR data quality studied by clinical researchers and a 
summary and critique of the methods that have been used to assess EHR data quality, specifically 
within the context of reusing clinical data for research. Our goal is to develop a systematic 
understanding of the approaches that may be used to determine the suitability of EHR data for a 
specific research goal. 
2.2 Methods 
We identified articles in the literature by performing a search of the literature using 
standard electronic bibliographic tools.  The literature search was performed by the first author on 
PubMed in February of 2012.  As observed by Hogan and Wagner in their literature review, there 
is no Medical Subheadings (MeSH) term for data quality,(8) so a brief exploratory review was 
performed to identify relevant keywords.  The final list included “data quality,” “data accuracy,” 
“data reliability,” “data validity,” “data consistency,” “data completeness,” and “data error.”  The 
MeSH heading for EHRs was not introduced until 2010, so the older and more general MeSH 
heading “medical record systems, computerized” was used instead.  The phrases “electronic 
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health record,” “electronic medical record,” and “computerized medical record” were also 
included in order to capture articles that may not have been tagged correctly.  We searched for 
articles including at least one of the quality terms and at least one of the EHR terms. Results were 
limited to English language articles. The full query is shown below. 
(“data quality” OR “data accuracy” OR “data reliability” OR “data validity” OR “data 
consistency” OR “data completeness” OR “data errors” OR “data error”) AND (electronic health 
record OR electronic medical record OR computerized medical record OR medical records 
systems, computerized [mh]) AND English[lang] 
This search produced 230 articles, all of which were manually reviewed by the first 
author to determine if they met selection criteria.  Specifically, the articles retained for further 
review 1) included original research using data quality assessment methods, 2) focused on data 
derived from an EHR or related system, and 3) were published in a peer-reviewed journal.  
Articles dealing with data from purely administrative systems (e.g. claims databases) were not 
included.  These inclusion criteria resulted in 44 relevant articles.  Next, we performed an in-
depth ancestor search, reviewing the references of all of the articles in the original pool of 44.  
This allowed us to identify an additional 51 articles, resulting in a final pool of 95 articles 
meeting our inclusion criteria that then were used to derive results in this study. 
From each article we abstracted the features of data quality examined, the methods of 
assessment used, and basic descriptive information including about the article and the type of data 
being studied.  Through iterative review of the abstracted data, we derived broad dimensions of 
data quality and general categories of assessment strategies commonly described in the literature.  
Finally, we reviewed the 95 articles again, categorizing every article based upon the dimension or 
dimensions being assessed, as well as the assessment strategies used for each of those 
dimensions.   
Prior to beginning this analysis, we searched for preexisting models of EHR data quality, 
but were unable to find any.  We decided that the potential benefits of adapting a data quality 
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model from another field were outweighed by the risks of approaching our analysis through the 
lens of a model that had not been validated in the area of EHR data quality.  Furthermore, using 
an existing model to guide analysis has the potential to obscure information contained in the 
data.(11) By imposing an existing model from a different discipline, we would have run the risk 
of missing important findings.  Therefore, we decided to use an inductive, data-driven coding 
approach.  This approach provides advantages over the deductive approach by allowing us better 
coverage of the dimensions and methods of data quality assessment.  
2.3 Results 
The majority of papers reviewed (73%) looked at structured data only, or at a 
combination of structured and unstructured data (22%).  For our purposes, unstructured data types 
include free-entry text, while structured data types include coded data, values from pre-populated 
lists, or data entered into fields requiring specific alpha-numeric formats. 
2.3.1 Summary of Data Quality Dimensions 
Ignoring variations due to lexical categories and negation, the articles contained 27 
unique terms describing dimensions of data quality.  Features of data quality that were mentioned 
or described but not assessed were not included in our analysis.  We grouped the terms together 
based on shared definitions.  A few features of good data described in the literature, including 
sufficient granularity and the use of standards, were not included in our analyses. This decision 
was made due to the limited discussion of these features, the fact that they could be considered 
traits of good data practice instead of data quality, and because no assessment methods were 
described. Overall, we empirically derived five substantively different dimensions of data quality 
from the literature.  The dimensions are defined below. 
• Completeness: Is a truth about a patient present in the EHR? 
• Correctness: Is an element that is present in the EHR true? 
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• Concordance: Is there agreement between elements in the EHR, or between the EHR and 
another data source? 
• Plausibility: Does an element in the EHR makes sense in light of other knowledge about 
what that element is measuring? 
• Currency: Is an element in the EHR a relevant representation of the patient state at a 
given point in time? 
The list of data quality terms and their mappings to the five dimensions described above 
are shown in Table 1.  The terms chosen to denote each of the dimensions were the clearest and 
least ambiguous from each of the groups.  There was a great deal of variability and overlap in the 
terms used to describe each of these dimensions.  “Accuracy,” for example, was sometimes used 
as a synonym for correctness, but in other articles meant both correctness and completeness.  The 
dimensions themselves, however, were abstracted in such a way as to be exhaustive and mutually 
exclusive based upon their definitions.  Every article identified could be matched to one or more 
of the dimensions.  
Table 2.1 Terms from literature to denote five common dimensions of EHR data quality. 
Completeness Correctness Concordance Plausibility Currency 
Accessibility Accuracy Agreement Accuracy Recency 
Accuracy Corrections 
made 
Consistency Believability Timeliness 
Availability Errors Reliability Trustworthiness  
Missingness Misleading Variation Validity  
Omission Positive 
predictive value 
   
Presence Quality    
Quality Validity    
Rate of 
recording 
    
Sensitivity     
Validity     
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2.3.2 Summary of Data Quality Assessment Methods 
A similar process was used to identify the most common methods of data quality 
assessment.  The strategies used to assess the dimensions of data quality fell into seven broad 
categories of methods, many of which were used to assess multiple dimensions.  These general 
methods are listed and defined below. 
• Gold standard: A dataset drawn from another source or multiple sources, with or without 
information from the EHR, is used as a gold standard. 
• Data element agreement: Two or more elements within an EHR are compared to see if 
they report the same or compatible information.  
• Element presence: A determination is made as to whether or not desired or expected data 
elements are present. 
• Data source agreement: Data from the EHR are compared to data from another source to 
determine if they are in agreement. 
• Distribution comparison: Distributions or summary statistics of aggregated data from the 
EHR are compared to the expected distributions for the clinical concepts of interest. 
• Validity check: Data in the EHR are assessed using various techniques that determine if 
values “make sense.” 
• Log review: Information on the actual data entry practices (e.g. dates, times, edits) is 
examined. 
A summary of which methods were used to assess which dimensions is shown in Table 2.  
The graph in Figure 1 shows the strength of the pairwise relationships between the dimensions 
and methods. Some of the methods were used to assess only certain dimensions of data quality, 
which other methods were applied more broadly. Element presence, for example, was used to 
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assess completeness, but none of the other dimensions. Data element agreement and data source 
agreement, however, were applied more broadly.  Most of the dimensions were assessed using an 
assortment of methods, but currency was only measured using a single approach.  
Table 2.2 Dimensions of data quality and methods of data quality assessment. In decreasing order of 
frequency, the dimensions are listed from left to right, and the methods from top to bottom. The numbers in the 
cells correspond to the article counts. 
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2.3.2.1 Completeness 
Completeness was the most commonly assessed dimension of data quality and was an 
area of focus in 61 (64%) of the articles. Generally speaking, completeness referred to whether or 
not a truth about a patient was present in the EHR.  Most of the articles used the term 
completeness to describe this dimension, but some also referred to data availability or missing 
data.  In others, completeness was subsumed into more general concepts like accuracy or quality.  
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Some articles cited the statistical definition of completeness suggested by Hogan and Wagner, in 
which completeness is equivalent to sensitivity.(8) 
 
Figure 2.1 Mapping between dimensions of data quality and data quality assessment. The weight of the edge 
connecting a dimension and method indicates the relative frequency of that combination. 
 
Many articles assessed EHR data completeness by using another source of data as a gold 
standard. The gold standards used included concurrently kept paper records,(12-18) information 
supplied by patients,(19-21) review of data by patients,(22-25) clinical encounters with 
patients,(26-28) information presented by trained standard patients,(29, 30), information 
requested from the treating physician,(31) and alternate data sources from which EHR elements 
were abstracted.(32, 33) A similar approach involved triangulating data from multiple sources 
within the EHR to create a gold standard.(34, 35)   
Other researchers simply looked at the presence or absence of elements in the EHR.  In 
some cases, these were elements that were expected to be present, even if they were not needed 
for any specific task.(36-50)  In other situations, the elements examined were dependent upon the 
task at hand, meaning that the researchers determined whether or not the EHR data were complete 
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enough for a specific purpose.(51-58) Other methods for assessing completeness included looking 
at agreement between elements from the same source,(57, 59-65) agreement between the EHR 
and paper records,(47, 66, 67) agreement between the EHR and another electronic source of 
data,(47, 68) and comparing distributions of occurrences of certain elements between 
practices(69) or with nationally recorded rates.(70-72)  
2.3.2.2 Correctness 
The second most commonly assessed dimension of data quality was correctness, which 
was included in 57 (60%) of the articles.  EHR data were considered correct when the 
information they contained was true.  Other terms that were commonly used to describe this 
concept included accuracy, error, and quality.  Occasionally, correctness included completeness, 
due to the fact that some researchers consider missing data to be incorrect (i.e., errors of 
omission).  The definition of correctness suggested by Hogan and Wagner states that data 
correctness is the proportion of data elements present that are correct, which is equivalent to 
positive predictive value.(8) 
Comparison of EHR data to a gold standard was by far the most frequently used method 
for assessing correctness.  These gold standards included: paper records;(12-18, 44, 73, 74) 
information supplied by patients through interviews(19, 20, 42, 75), questionnaires,(21, 76) data 
review,(22, 23, 25, 77) or direct data entry;(43) clinical encounters with patients;(26, 28, 78) 
information presented by trained standard patients;(29, 30) automatically recorded data;(79) 
contact with the treating physician;(31, 58, 80) and alternate data sources from which information 
matching EHR elements were abstracted.(32, 33) Some researchers developed gold standards by 
extracting and triangulating data from within the EHR.(34, 35, 76, 81)  
The second most common approach to assessing correctness was to look at agreement 
between elements within the EHR.  Usually this involved verifying a diagnosis by looking at 
associated procedures, medications, or lab values.(46, 50, 57, 59, 61-63, 82, 83)  Similarly, some 
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articles reported on agreement between related elements(65, 84) and errors identified through the 
examination of the use copy and paste practices(85, 86). Other researchers looked specifically at 
agreement between structured elements and unstructured data within EHRs.(51, 87)  One of the 
more formal approaches described for assessing correctness was the data quality probe, proposed 
by Brown and Warmington, which is a query that, when run against an EHR database, only 
returns cases with some disagreement between data elements.(88, 89)  
A few articles described the use of validity checks to assess correctness. These included 
review of changes of sequential data over time(90), identifying end digit preferences in blood 
pressure values(91, 92), and comparing elements to their expected value ranges. (32, 84) Two 
other approaches to were using corrections seen in log files as a proxy for correctness,(93) and 
comparing data on the same patients from a registry and an EHR.(94) 
2.3.2.3 Concordance 
Sixteen (17%) of the articles reviewed assessed concordance.  Data were considered 
concordant when there was agreement or compatibility between data elements.  This may mean 
that two elements recording the same information for a single patient have the same value, or that 
elements recording different information have values that make sense when considered together 
(e.g. biological sex is recorded as female, and procedure is recorded as gynecologic exam).  
Measurement of concordance is generally based upon elements contained within the EHR, but 
some researchers also included information from other data sources. Common terms used in the 
literature to describe data concordance include agreement and consistency. 
The most common approach to assessing concordance was to look at agreement between 
elements within the EHR,(38, 40, 51, 95) especially diagnoses and associated information like 
medications or procedures.(60, 96, 97)  The second most common method used to assess 
concordance was to look at the agreement of EHR data with data from other sources. These other 
sources included billing information,(98) paper records,(99-101) patient-reported data,(102) and 
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physician-reported data.(103) Another approach was to compare distributions of data within the 
EHR to distributions of the same information from similar medical practices (46, 69) or with 
national rates.(31) 
2.3.2.4 Plausibility 
Seven (7%) of the articles assessed the plausibility of EHR data.  In this context, data 
were plausible if they were in agreement with general medical knowledge or information and 
were therefore feasible.  In other words, assessments of plausibility were intended to determine 
whether or not data could be trusted or if they were of suspect quality. Other terms that were used 
to discuss and describe EHR data plausibility include data validity and integrity. 
The most common approach to assessing the plausibility of EHR data was to perform 
some sort of validity check to determine if specific elements within the EHR were likely to be 
true or not.  This included looking for elements with values that were outside biologically 
plausible ranges or that changed implausibly over time(68) or zero-valued elements.(93)  Other 
researchers compared distributions of data values between practices(59, 104) or with national 
rates,(105, 106) or looked at agreement between related elements.(44, 93) 
2.3.2.5 Currency 
Currency of EHR data was assessed in four (4%) of the 95 articles.  Currency was often 
referred to in the literature as timeliness or recency.  Data were considered current if they were 
recorded in the EHR within a reasonable period of time following measurement or, alternatively, 
if they were representative of the patient state at a desired time of interest. In all four articles, 
currency was assessed through the review of data entry logs.  In three of the four, researchers 
reviewed whether desired data were entered into the EHR within a set time limit.(42, 61, 79)  In 
the fourth, researchers considered whether each type of data element was measured recently 
enough to be considered medically relevant.(54) 
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2.4 Discussion 
We identified five dimensions of data quality and seven categories of data quality 
assessment methods. Examination of the types of methods used, as well as overlap of the methods 
between dimensions, reveals significant patterns and gaps in knowledge.  Below, we explore the 
major findings of the literature review, specifically highlighting areas that require further 
attention, and make suggestions for future research. 
2.4.1 Terminology and dimensions of data quality 
One of the biggest difficulties in conducting this review resulted from the inconsistent 
terminology used to discuss data quality.  We had not expected, for example, the overlap of terms 
between dimensions, or the fact that the language within a single article was sometimes 
inconsistent.  The clinical research community has largely failed to develop or adopt a consistent 
taxonomy of data quality.  
There is, however, overlap between the dimensions of data quality identified during this 
review and those described in pre-existing taxonomies and models of data quality. Wang and 
Strong’s conceptual framework of data quality, for example, contains fifteen dimensions, grouped 
into four categories: intrinsic, contextual, representational, and accessibility.(107) Our review 
focused on intrinsic (inherent to the data) and contextual (task-dependent) data quality issues. The 
dimensions we identified overlapped with two of the intrinsic features (accuracy and 
believability, which are equivalent to correctness and plausibility) and two of the contextual 
features (timeliness, which is equivalent to currency, and completeness). The only dimension we 
identified that does not appear in Wang and Strong’s framework is concordance. 
The Institute of Medicine (IOM) identified four attributes of data quality relevant to 
patient records: completeness, accuracy, legibility, and meaning (related to 
comprehensibility).(108)  As the IOM points out, electronic records by their nature negate many 
of the concerns regarding legibility, so we are left with three relevant attributes, two of which we 
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identified through our review. Meaning is a more abstract concept and is likely difficult to 
measure objectively, which may be why we did not observe assessments of this dimension in the 
literature.   
Although the five dimensions of data quality derived during our review were treated as 
mutually exclusive within the literature, we feel that only three can be considered fundamental: 
correctness, completeness, and currency.  By this we mean that these dimensions are non-
reducible, and describe core concepts of data quality as it relates to EHR data reuse.  
Concordance and plausibility, on the other hand, while discussed as separate features of data 
quality, appear to serve as proxies for the fundamental dimensions when it is not possible to 
assess them directly.  This supposition is supported by the overlap observed in the methods used 
to assess concordance and plausibility with those used to assess correctness and completeness.  A 
lack of concordance between two data sources, for example, indicates error in one or both of 
those sources: an error of omission, resulting in a lack of completeness, or an error of 
commission, resulting in a lack of correctness.  Similarly, data that do not appear to be plausible 
may be incorrect, as in the case of a measurement that fails a range check, or incomplete, such as 
aggregated diagnosis rates within a practice that do not match the expected population rates.  It 
may be that correctness, completeness, and currency are properties of data quality, while 
plausibility and concordance are methodological approaches to assessing data quality.  
Additionally, researchers may refer to plausibility or concordance when they believe that there 
are problems with completeness or correctness, but have no way to be certain that errors exist or 
which data elements might be wrong.  
2.4.2 Data quality assessment methodology 
We observed a number of noteworthy patterns within the literature in terms of the types 
of data quality assessments used and the manner in which data quality assessment was discussed.  
For example, 37 of the 95 articles in our sample relied upon a gold standard to assess data quality.  
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There are a few problems with this approach.  First, the data sources used could rarely be 
considered true gold standards.  Paper records, for example, may sometimes be more trusted than 
electronic records, but they should not be considered entirely correct or complete.  Perhaps more 
importantly, a gold standard for EHR data is simply not available in most cases.  This will 
become more problematic as the use of de-identified datasets for research becomes more 
common.  A “fitness for purpose” approach, which suggests that the quality of each dataset 
compiled for a specific task must be assessed, necessitates the adoption of alternatives to gold 
standard-based methods. 
In addition to the overreliance upon gold standards, the majority of the studies we 
identified relied upon an “intuitive” understanding data quality and used ad hoc methods to assess 
data quality.  This tendency has been observed in other fields as well.(107, 109)  Most of the 
studies included in this review presented assessment methodologies that were developed with 
minimal empirical or theoretical basis.  Only a few researchers made the effort to develop 
generalizable approaches that could be used as a step towards a standard methodology.  Faulconer 
and de Lusignan, for example, proposed a multi-step, statistically driven approach to data quality 
assessment.(61) Hogan and Wagner suggested specific statistical measures of the correctness and 
completeness of EHR elements that have been adopted by other researchers.(8)  Certain methods, 
including comparing distributions of data from the EHR to expected distributions or looking for 
agreement between elements within the EHR, lend themselves more readily to generalization.  
Brown and Warmington’s data quality probes, for example, could be extended to various data 
elements, though they require detailed clinical knowledge to implement.(88, 89)  Some 
researchers looking at the quality of research databases pulled from general practices in the 
United Kingdom have adopted relatively consistent approaches to comparing the distributions of 
data concerning specific clinical phenomena to information from registries and surveys.(31, 70, 
71, 106)  In most cases, however, the specific assessment methods described in the literature 
would be difficult to apply to other datasets or research questions.  If the reuse of EHR data for 
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clinical research is to become common and feasible, development of standardized, systematic 
data quality assessment methods is vital. 
Additionally, if as a field we intend to adopt the concept of “fitness for purpose”, it is 
important to consider the intended research use of EHR data when determining if they are of 
sufficient quality.(110) Some dimensions may prove to be more task-dependent, or subjective, 
while others are essentially task-independent, or objective.(109) It will be important to develop a 
full understanding of the interrelationships of research tasks and data characteristics as they relate 
to data quality.  For example, the completeness of a set of data elements required by one research 
protocol may differ from the completeness required for a different protocol.  Many factors, 
including clinical focus, required resolution of clinical information, and desired effect size, can 
affect the suitability of a dataset for a specific research task.(26) 
2.4.3 Future Directions 
We believe that efforts to reuse EHR data for clinical research would benefit most from 
work in a few specific areas: adopting a consistent taxonomy of EHR data quality; increasing 
awareness of task-dependence; integrating work on data quality assessment from other fields; and 
adopting systematic, statistically-based methods of data quality assessment.  A taxonomy of data 
quality would enable a structured discourse and contextualize assessment methodologies.  The 
findings in this review regarding the dimensions of data quality may serve as a stepping-stone 
towards this goal.  Task-dependence is likely to become a growing issue as efforts to reuse EHR 
data for research increase, particularly since data quality assessment does not have a one-size-fits-
all solution.  One approach to addressing the problem of EHR data quality and suitability for 
reuse in research would be to look at what has been done outside of clinical research, since data 
quality has been an area of study in fields ranging from finance to industrial engineering.  Finally, 
it is important that the clinical researchers begin to move away from ad hoc approaches to data 
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quality assessment.  Validated methods that can be adapted for different research questions are 
the ideal goal. 
2.4.4 Limitations 
There were a number of limitations to this review.  First, the search was limited.  Due to 
the lack of MeSH term for data quality and the variation in terminology used to discuss data 
quality, it is possible that our original search may have missed some relevant articles.  We believe 
that our decision to review the references of each article improved the saturation of our sample.   
It is also important to note that our classification process was largely subjective and was 
performed by only one of the authors.  It is possible that the original researchers might disagree 
with our interpretations.  We chose to use an iterative process to label and categorize the 
dimensions of data quality and methods of assessment described in each article in an effort to 
develop a consistent coding scheme.   
Finally, it is likely that the dearth of literature discussing data quality in the reuse of EHR 
data for clinical research is due in part to underreporting. A common first step in analyzing any 
dataset is to review distributions, summary statistics, and histograms, but this process is rarely 
described in publications. Such methods are therefore likely to be underrepresented in this 
review.  Greater transparency regarding data cleaning or checking steps would be advisable, as it 
could help to establish acceptable reporting standards for the reuse of EHR data in research.  
2.5 Conclusion 
The secondary use of EHR data is a promising area of research.  However, the problems 
with EHR data quality necessitate the use of quality assessment methodologies to determine the 
suitability of these data for given research tasks. In this review of the literature we have identified 
the major dimensions of data quality that are of interest to researchers, as well as the general 
assessment techniques that have been utilized. Data quality is not a simple problem, and if the 
reuse of EHR data is to become an accepted approach to medical research, the clinical research 
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community needs to develop validated, systematic methods of EHR data quality assessment.  We 
encourage researchers to be consistent in their discussion of the dimensions of data quality, 
systematic in their approaches to measuring data quality, and to develop and share best practices 
for the assessment of EHR data quality in the context of reuse for clinical research. 
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  Chapter 3: Researcher Perceptions 
Chapter 3: Clinical Research Attitudes and 
Perceptions Regarding Electronic Health 
Record Data Quality1 
3.1 Introduction 
The reuse of electronic health record (EHR) data in research is one of the most promising 
approaches to comparative effectiveness research, patient-centered outcomes research, and the 
development of a learning healthcare system.(1-5) These promises include increased efficiency, 
decreased cost, and improved representation of target patient populations. A number of 
stakeholders, including patients, clinicians, researchers, and policy-makers, stand to influence and 
benefit from the secondary use of EHR data.  Clinical researchers, in particular, are likely to be 
1 This chapter is a manuscript in preparation to be submitted to a peer-reviewed journal.  Nicole Weiskopf 
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responsible for the translation of information acquired during clinical care processes into 
actionable knowledge.(6) 
Although significant work has been done on the acceptance of EHRs as clinical tools,(7-
10) little attention has been paid to the factors influencing EHR data reuse. This is especially 
important in light of the growing focus on EHR data quality.  EHR data quality has been a topic 
of interest since EHRs and other health information technology systems were first introduced,(11-
13) but it is only in past decade that there has been attention paid to the necessity for 
comprehensive and systematic approaches to EHR data quality within the context of EHR data 
reuse.(14-16) 
In order to enable the reuse of EHR data, it is important to understand researcher 
perceptions of and attitudes towards EHR data and their suitability for research endeavors.. What 
are researcher perceptions of EHR data quality? Are these perceptions a barrier to the reuse of the 
data?  An assessment of the needs of researchers in regards to EHR data quality and reuse is 
necessary to guide ongoing and future research efforts. 
The most direct way to gain an understanding of researcher needs, attitudes, and 
perceptions as they relate to EHR data quality within the context of EHR data reuse in research is 
to ask them.  Therefore, we conducted a series of semi-structured interviews with clinical 
researchers within the Columbia University Medical Center community.  Our goal was to gain an 
understanding of actual researcher experiences conducting research with EHR data. We 
hypothesized that clinical researchers, inasmuch as they were aware of EHR data quality 
problems, saw data quality as a barrier to research based on EHR data.     
3.2 Methods 
3.2.1 Sample 
The target population for this study was clinical researchers within the Columbia 
University Medical Center community.  We used purposive sampling in order to identify the most 
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representative range of views on EHR data quality and EHR data reuse.(17) Specifically, we 
wished to identify researchers who represented various dimensions of experience: seniority, 
gender, clinical training, research experience, and experience using EHR data in research.   
Though recommendations regarding sample sizes vary widely, previous research has 
indicated that the majority of relevant themes can be identified using semi-structured interviews 
with six participants.(18) We set an initial goal of ten interviews, with the understanding that 
further interviews would be conducted if saturation was not achieved.(19) 
3.2.2 Procedure 
Institutional Review Board and Consent  
The study was determined to be exempt from the Institutional Review Board approval 
process by the Columbia University Medical Center Institutional Review Board.  All participants, 
however, were asked to provide informed consent prior to being interviewed.  Compensation in 
the form of a twenty-five dollar pre-paid credit card was provided to all participants upon 
completion of the interview. 
Recruitment 
Potential participants were contacted by email.  The email contained basic information on 
the study and included the information sheet and consent form (see Appendix A) as an 
attachment.   
Instrument 
We used Phase 3 of the Precede-Proceed model as the basis for our instrument 
design.(20) Although the Precede-Proceed model was developed for guiding the development, 
implementation, and evaluation of interventions to alter health-related behaviors, the model can 
be extended and adapted to other behaviors of interest, including use of health-related 
technologies.(21, 22)  
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Phase 3 of the Precede-Proceed model focuses on potentially modifiable factors that may 
influence target behaviors—specifically predisposing, enabling, and reinforcing factors.  Within 
the context of researcher re-use of EHR data in research, this means that Phase 3 can be used to 
guide an exploration of researcher perceptions of EHR data quality, their attitudes towards EHR 
data reuse, the ease or difficulty of reusing EHR data, and the rewards or costs of reusing EHR 
data.   
We prepared a set of experience-based questions to guide semi-structured interviews, 
each of which was intended to last between 30 and 60 minutes.  Rather than asking directly about 
predisposing, enabling, and reinforcing factors, the questions instead invite the participants to 
describe their experience using EHR data in research (if they have such experience), their 
perceptions of EHR data quality, and their intention to use EHR data in research going forward.  
A wrap-up question was also included at the end of all interviews.   By asking broad, open-ended 
questions, our hope was to elicit a broad range of experiences and perceptions from the 
participants.(23, 24) The complete interview instrument is included in Appendix B. 
Data Collection 
All interviews were recorded with the participants’ permission.  Immediately following 
each interview, the digital recordings were transferred to a secure computer and the interviewer’s 
initial thoughts and impressions were written down.  Each interview recording was reviewed and 
de-identified using the Audacity audio editor (http://audacity.sourceforge.net/).  Following de-
identification, the digital recordings were transcribed by a professional transcription service.  The 
transcripts were compared to the digital recordings and edited for accuracy.  All electronic files 
were stored in an encrypted file on a secure server.  Paper consent forms were saved in a locked 
file in a secure office.  
Analysis 
The interview transcripts were analyzed through content analysis, using a combined top-
down and bottom-up approach.(25, 26) Coding was performed iteratively,(27) and began with the 
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top-down step. An initial coding scheme was developed based upon the three major categories of 
Phase 3 of the Precede-Proceed model.  Additional codes, related to data quality categories and 
assessment methods, were identified from a previous literature review on EHR data quality 
assessment.(28)  A first pass through the transcripts was then performed, during which existing 
codes were assigned where possible, and important excerpts that did not fit into the existing 
scheme were identified.   
During the deductive half of the analysis process, the coding scheme was updated based 
upon the first round of analysis.  New themes and categories were identified and old ones were 
eliminated or edited.  During a second pass through the transcripts, the updated coding scheme 
was applied, and final refinements were made to the coding scheme.  
3.2.3 Ensuring Trustworthiness 
Member Checks 
Member checks were performed at two stages in the data collection and analysis process.  
First, during the interviews the interviewer reflected phrases and concepts back to the participants 
to clarify and confirm understanding.   
Following the completion of the final coding scheme and coding of data, approximately 
28 months after the initial interviews were conducted, all participants were contacted by email 
and asked to confirm the major themes identified from their individual interviews.(29, 30) Each 
participant received an email with a brief description of the member check process.  An encrypted 
document, containing a selection of the major themes identified from that participant’s interview, 
was attached.  A second email was sent containing a password to decrypt the attachment.  Each 
participant was asked to respond indicating whether the themes faithfully captured their beliefs, 
attitudes, and experiences with regards to electronic health record data and data quality at the time 
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Documentation of the interview and analysis processes was maintained over the course of 
the study, creating an audit trail.  The trail included the interview guide, the initial coding scheme, 
the first pass of coded data, the final coding scheme, the second pass of coded data, and detailed 
notes on the analysis and coding process.  These documents were audited by Suzanne Bakken, a 
faculty member, to assess the reliability of the analysis and resulting findings.(30-32)   
3.3 Results 
3.3.1 Participants 
Ten clinical researchers were interviewed, though one interview was dropped because the 
interview guide could not be completed in the time allotted. The nine remaining participants had 
an average age of 43, with a standard deviation of 17 years.  Six of the nine participants were in 
their thirties.  Four of the participants were female and five were male.  Eight of the participants 
were medical doctors, though not all had practiced clinically, and three held doctorates besides 
medical degrees.    
3.3.2 Coding Scheme 
 Overall, 38 unique thematic codes were identified and used.  The complete 
coding scheme is presented in Figure 1. The coding scheme was mapped to the three primary 
factor groups from the Precede-Proceed model (predisposing, enabling, and reinforcing factors).  
The majority of themes derived during the deductive analysis phase fell into predisposing 
category.   
3.3.3 Predisposing Factors 
Most findings fell into the predisposing factors category, which includes researcher 
knowledge, perceptions, and attitudes regarding data quality as a general concept, the quality of 
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EHR data specifically, and the reuse of EHR data in research.  Seven thematic categories were 
identified: knowledge of relevant categories of data quality, beliefs about the state of EHR data 
quality, beliefs about factors that impact EHR data quality, beliefs about others’ attitudes towards 
EHR data quality and data reuse, general attitudes towards EHR data reuse, and beliefs about how 
EHR data should be reused. 
3.3.3.1 Knowledge of relevant data quality problems 
The participants described a number of different data quality problems and concerns that 
they knew of that they thought were relevant to EHR data. Seven basic dimensions of data quality 
were derived from the problems and concerns: completeness, correctness, fragmentation, 
granularity, concordance, non-structured, and signal-to-noise.   
3.3.3.2 Beliefs about the state of EHR data quality 
In terms of participants beliefs about the current state of EHR data quality, most reported 
either that they did not trust the data, or that they had mixed feelings regarding the 
trustworthiness of the data (see Table 1 for examples).  They also believed that there was 
variation in quality depending upon institutes, as well as the types of data recorded (e.g. 
medication orders, laboratory results, notes, billing data, etc.).   
Table 3.1 Predisposing factors related to beliefs about the state of EHR data quality: overall researcher trust in 
EHR data. 
Theme Representative Participant Statements 
EHR data cannot be 
trusted 
It’s legendary among trialists that what’s in a chart—it’s an electronic 
health record now but it was a chart before—the kind of rules about 
what you put in there, who puts it in, and how careful they are…is 
pretty sloppy. 
I think it’s much better than it probably used to be, but I think it does 
have a long way to go before it’s something I feel entirely comfortable 
without having to go through a lot of internal validation steps. 
Conflicted feelings 
about EHR data 
If [data quality] was like, one to ten, maybe a six.  I think—we tend to 
be pretty comprehensive, I think accuracy—we tend to be overall 
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3.3.3.3 Beliefs about factors that influence EHR data quality 
The participants identified three primary types of factors that they believed influenced the 
quality of EHR data: traits of the data, system features, and user (e.g. clinician) behaviors (see 
Table 2 for examples).  Data traits include mechanisms and requirements at the variable level.  
Whether an element is required or optional, automatically recorded or manually recorded, 
objective (e.g. lab result) or subjective (e.g. diagnosis), and structured or unstructured were all 
seen as potentially influencing the quality of the relevant data.  Some participants, for example, 
thought that manually recorded data were likely to be of better quality than automatically 
recorded data, since they invited some degree of human validation, while other participants 
believed the opposite, and expected that automatically recorded information was likely to be more 
trustworthy. Those who mentioned optional versus required elements believed that optional 
variables were more likely to be of good quality than required elements, since the latter might be 
entered without care simply to progress to the next data entry step.  Objective variables were 
generally believed to be of better quality than subjective elements.  Beliefs regarding structured 
versus unstructured variables were split.  Some thought that clinicians were more likely to 
faithfully capture nuanced information in a note, while others thought that the very nature of 
unstructured data made it unsuitable for reuse. 
Most participants cited similar system features or issues that they believed negatively 
influenced EHR data quality: EHRs are designed for billing, rather than clinical care or research, 
and EHRs and institutional health information technology systems tend to be fragmented (either 
within an EHR, or between multiple EHRs and related systems that are meant to function as a 
single system).  Participants expressed significant frustration regarding their perceptions that 
EHR design, implementation, and use are guided by administrative and billing needs, which they 
believed resulted in data that was of insufficient quality for research.  Fragmentation was believed 
to make it difficult to identify, collect, and validate relevant data. 
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In terms of user behaviors, some participants believed that clinicians were so focused on 
clinical practice that they paid little attention to the quality of the data they entered beyond what 
they felt was strictly necessary for caring for a patient.  Not all participants who mentioned this 
issue described it as a negative, but rather as a simple fact of the care process. Similarly, some 
participants believed that more explicit knowledge of how or if EHR data might be reused might 
influence clinicians to pay more attention to data quality at the time of data entry. 
Table 3.2 Predisposing factors related to beliefs about factors that influence EHR data quality: data traits, 
system features, and user behaviors that participants believed might influence the quality of EHR data. 
Theme Representative Participant Statements 
Traits of data If data collection can be automated, I think you can have a higher 
confidence that the data are accurate. 
So for instance, if somebody came to me and they were very interested 
in blood pressure in the ICU…there are tags that nurses make to blood 
pressure measurements that they’ve verified and validated.  And so in 
the data, I’m sure that there is an embedded tag that indicates that a 
human being has seen and verified this result.  And I might suggest 
that, if possible, only those values be used…. Anytime a human being 
hasn’t laid eyes on a result and had a chance to flag it as valid or 
invalid, there’s obviously a risk of a mistake. 
System features When you just go with people who with blood pressure measurements 
and then you like, wait, you want those people who are high blood 
pressure but they are treated so their blood pressure is lower now, you 
need to code them as hypertensives as well. 
User behaviors The data was extracted from a team that is employed by the hospital.  
And they feel very strongly that I need to work with the data in a 
particular environment supported by the hospital, meaning they’re not 
just going to give me a bunch of information from patients.  And 
working within that environment is sort of a new concept…that has 
been the biggest limitation. 
 
3.3.3.4 Beliefs about other’s attitudes towards EHR data quality and reuse 
Some of the participants believed that their perceptions of and attitudes towards EHR 
data quality and EHR data reuse were different from those of their fellow researchers or 
clinicians.  Specifically, some participants believed that they were more aware of the limitations 
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of EHR data than others in their position.  One of the more senior participants believed that 
younger clinicians, particularly those who had always worked with EHRs instead of paper 
records, would be likely to trust the data coming from EHRs. 
3.3.3.5 Attitudes towards the reuse of EHR data 
The participants had varying attitudes towards the reuse of EHR data.  Some felt 
positively towards it, some conflicted, and others negatively (see Table 3 for examples).  Some 
participants expressed inconsistent attitudes over the course of a single interview.  Most of the 
few positive comments regarding EHR data reuse were with qualification.  Simply having the 
data available was seen as a positive, when the converse was not having the data at all, and 
electronic data were seen as more accessible and less fragmented than paper records.  The 
majority of negative attitudes towards the reuse of EHR data stemmed from concerns about 
retrospective research broadly (e.g. unknown confounders), the potential to intentionally or 
unintentionally alter or influence findings through the data transformation and cleaning processes, 
and the suspected poor quality of EHR data.  The participants who expressed conflicted attitudes 
felt that there were both significant limitations to and major opportunities in the reuse of EHR 
data in research. 
Table 3.3 Predisposing factors related to attitudes towards the reuse of EHR data in research. 
Theme Representative Participant Statements 
Positive attitudes I think it’s definitely a step forward from where things used to be.  It’s 
much better than hand inputting data in separate silos…over and over 
every time you want to get a project done, like having some basic stuff 
that’s available for everybody to use. 
It definitely gives you data are that suitable for research…. 
Negative attitudes But even just looking at like 10 charts, like there were so many holes 
that we like discarded using the data whatsoever and we don’t have the 
manpower to go back, to review like, five of those charts. For me it 
took like a couple of hours.  So we wanted to do this for something 
like a thousand patients and we don’t have like staffing.  So it’s sort of 
like we are waiting on that project until we know the data’s better. 
There’re a lot of hidden choices about how do I define the date of 
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diagnosis, which is not as well-defined as I thought it would be.  How 
do I define the presentation of a disease that can be different for a lot 
of people?  And in order for you to talk about all of that, the methods 
section would be twenty pages long. 
Conflicted attitudes I’m just saying, you know what?  [EHR data] is what it is.  And people 
have spoken about problems with it, but that’s systemic error, and this 
is some additional pieces of the puzzle that probably give us more 
insight into important disease processes.  And I think that’s sort of 
fine, it’s sort of saying that I’m not agreeing with the entire 
record…let’s sort of all accept the problems with it. 
I mean, I think it’s not even—starting at this point in time, it’s not 
even a question of positive or negative, because I think it’s the way of 
the future, or the way of the present. 
 
Beliefs about how to reuse EHR data 
 The participants had a number of beliefs regarding how EHR data should be 
reused, both in terms of the processes used and the types of research being performed (see Table 
4 for examples). In terms of the latter, some participants believed that EHR data were best-suited 
to preliminary research and hypothesis generation, and that results from EHR-based research 
should be confirmed using more traditional studies or data. Many shared the opinion that EHR 
data required substantial validation prior to reuse, and that the processes of identifying, 
validating, and reusing the data should be guided by individuals with relevant clinical and 
institutional expertise (e.g. nurses or physicians).  Others suggested that metadata, which could 
include substantial information about the recording of a piece of data (e.g. clinician, location, 
etc.) as well as previous validation efforts, be attached to EHR data, so that researchers interested 
in using the data would have more information with which to inform the reuse process. 
Table 3.4 Predisposing factors related to beliefs about how to reuse EHR data in research. 
Theme Representative Participant Statements 




I think, you at least initially, until you know that, for your set of 
questions, that the de-identified dataset is pretty accurate, at least 
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Or you’re putting a grant in and you need like some preliminary data 
that looks encouraging or interesting or whatever.  And if you don’t 
have it there, people reading the grant are much less enthusiastic about 
giving a high score if you don’t show them something that can 
encourage them to believe in you. 
Clinical and 
institutional expertise 
should inform reuse 
I think it’s hard to use [EHR data] when it’s pulled straight from a 
database without having someone clinically or -- with clinical 
knowledge or background to review it, to use it and think that the data 
quality is good.  I don’t think that we feel comfortable enough like that 
to do it.  And I think it’s hard like even, you know, even one person 
reviewing a chart, even if you know, like two different people review 
the same chart and pull on what they think is the relevant data for a 
patient, like labs, or meds or diagnosis.  Like, they may come with 
different answers as well.  So it’s not saying that humans are perfect 
and the chart review that like looks at everything over a time 
chronologically is necessarily more accurate.  It probably can account 
for some of the variations, the computers that doesn’t sort of check for 
little things right -- like the one data that the lab got the wrong value 
for potassium. So like, I think that overall, we feel like it’s probably 
more reliable and we still need to check all of it manually. 
Finding very good clinicians and sitting down.  So that’s sort of my 
philosophy right now and we’re writing this sort of lessons learned 
piece.  It’s basically, if you need to do any research on this, just have 
to be a multidisciplinary team… there’s no way around it basically and 
you just need physicians who are dealing with this on a daily basis, 
informaticians and -- of course the traditional people like statisticians 
and epidemiologists, that kind of thing is fine but you just can’t do it 
with just one person. 
EHR data require 
validation prior to 
reuse 
I haven’t actually worked with data points that I know are going to be 
filled with unreliable things, but the way that I would handle that is the 
way that anybody would handle a large data set that they weren’t 
responsible for collecting.  They would run frequencies, they would 
look for clear outliers, one blood glucose of 500 in a patient who has 
blood glucoses in the normal range is more likely to be a statistical 
outlier or mistake or whatever.  And those patients, if you have the 
luxury, you flag those and you either throw out the data entirely and 
call it missing or you go back to the chart and verify that it was real. 
Metadata should be 
attached to EHR data 
There needs to be a data dictionary with a clear delineation of what the 
source of the information is plus indicators if that element came from 
different sources…what the source of that information came from so 
you can be selective about how you use it.  There should be, whether 
the researcher does it or whether it’s published—and it would be great 
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if it were pre-published—indicators of quality for those select 
variables that people felt were important and prone to 
misinterpretation, misclassification or whatever.  I guess I can find out 
how many missing values there are in a particular variable, but in 
terms of the dataset as a whole, I would like to know for each of these 
key variables, how many are missing and how many not, where 
they…came from and information about other people’s experiences….  
That kind of thing, so that a researcher can make a choice.  If that is 
their major outcome, they—or just a covariate—they can make a 
choice as to whether that is a good use of the data. 
 
3.3.4 Enabling Factors 
The enabling factors cited by participants included the availability and accessibility of 
EHR data, identifying relevant patients for data reuse, and the skills required to reuse the data 
(see Table 5 for examples).  Many of the participants complained of difficulty gaining access to 
the data they wanted, largely because of the institutionally-mandated process researchers must go 
through when requesting EHR data. Some participants also said that the cohort identification 
process was deceptively difficult, in part because of the limited reliability of diagnoses and 
related data.  Initial queries may have limited sensitivity, specificity, or both, leading to an 
extended, iterative query process, as well as manual review of results.  Lastly, some described 
lacking the specific skills needed to work with the data after gaining access.  This may be due to 
the format the data are extracted to, or special environments where researchers must conduct their 
work. 
Table 3.5 Enabling factors: factors influencing ease or difficulty of researcher reuse of EHR data in research. 
Theme Representative Participant Statements 
Availability and 
accessibility of data 
That’s a big barrier here.  I mean, you can wait a long time to get 
results because there’s really just two people writing programs to pull 
the stuff out.  But if you start just letting anybody do it, I suspect you 
would have a lot of misunderstanding about where things were and 
whatnot.  So it just seems like that’s an awfully small—they probably 
ought to charge a fair price for it, put it in the grants as an expense, 
have a little more infrastructure to deal with it. 
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It would be a lot easier if you could use the information that’s already 
in the electronic record and database that -- just download that into the 
database so that correlates with all the other clinical information.  
That’s a major disadvantage but that’s I guess, technical or political or, 
you know, commercial, I'm not sure what -- I mean there’s lot of 
reasons why it’s not being done. 
Identification of 
relevant data 
When you just go with people who with blood pressure measurements 
and then you like, wait, you want those people who are high blood 
pressure but they are treated so their blood pressure is lower now, you 
need to code them as hypertensives as well. 
Skills required for 
data reuse 
The data was extracted from a team that is employed by the hospital.  
And they feel very strongly that I need to work with the data in a 
particular environment supported by the hospital, meaning they’re not 
just going to give me a bunch of information from patients.  And 
working within that environment is sort of a new concept…that has 
been the biggest limitation. 
 
3.3.5 Reinforcing Factors 
The participants reported two primary factors rewarding the choice to reuse EHR data: 
the facilitation of research and the facilitation of publication (see Table 6 for examples).  They 
felt that reusing EHR data could increase the efficiency of research and increase the number of 
research questions that could be answered.  These improvements in the research process, in turn, 
could lead to an increase in papers published.   
Table 3.6 Reinforcing factors: costs and benefits to researcher reuse of EHR data in research. 
Theme Representative Participant Statements 
Facilitation of 
research 
EHR [data] is the promise for all the comparative effectiveness 
research, right? 
You have to have a little bit of skepticism, don’t trust the data 
implicitly, use it for what it is and certainly, it’s better than not having 
it and it facilitates a tremendous amount of research that wouldn’t be 
possible otherwise without exhaustive chart reviews or manual 
processing, so it has huge benefits, but it’s not a panacea. 
Facilitation of 
publication 
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3.4 Discussion 
The enabling and reinforcing factors identified from the interviews were mostly in 
agreement with what is already known about the secondary use of EHR data. Some of the 
predisposing factors, however, were not in line with commonly accepted wisdom about secondary 
use.  Clinical researchers have certain beliefs regarding “best practices” in EHR data reuse that 
are not currently addressed, and should be incorporated into workflows, models, and 
methodological approaches to EHR data quality assessment and reuse.  
3.4.1 Reinforcing and Enabling Factors 
The primary reinforcing factors identified from the interviews are very much in 
agreement with the factors currently driving the secondary use of EHR data: data reuse can 
improve efficiency and facilitate the research process and publication.(33, 34)  The enabling 
factors identified were similarly unsurprising.  Data accessibility and ease-of-use have been 
highlighted as an important (and problematic) issues within the informatics and broader 
researcher communities. Data security, governance, and availability are all ongoing topics of 
research.(35-37)  Cohort identification has also been identified as a deceptively complicated 
task,(38) and is the central focus of the eMERGE Network.(39)  
3.4.2 Conceptualizations of Data Quality 
Learning how clinical researchers view data quality is an important step in encouraging 
and improving the secondary use of EHR data.  The participants in this study identified seven 
categories of data quality: completeness, correctness, fragmentation, granularity, concordance, 
structured, and signal-to-noise.  There is a certain degree of overlap with Wang and Strong’s 
popular model of data quality, which includes accuracy, completeness, and concise representation 
among its 15 dimensions.(40)  
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Fragmentation, concordance, granularity, and signal-to-noise may represent the issues of 
data quality that arise specifically from the use of EHRs and other health information technology.  
The requirement that multiple information systems work in concert, which can lead to problems 
of fragmentation and lack of concordance, is common within large medical centers and systems, 
where there are often different EHRs for inpatient care, office-based practices, emergent care, etc.  
Data may also be recorded multiple times within the same system, leading to the same problems.  
The longitudinal nature of patient care, along with copy-and-paste problems,(41) can make it 
difficult to identify and locate the relevant data for a patient of interest. Finally, the granularity of 
data is extremely important in healthcare.  Data that are too granular can be difficult to group 
together meaningfully, while data that are not granular enough may not provide sufficient 
information.  It is therefore unsurprising that these four categories of data quality are more likely 
to be found within the informatics literature. Hersh, et al., for example, describe unstructured 
notes, multiple data sources, and granularity as potential causes of problems with the secondary 
use of EHR data in comparative effectiveness research, in addition to the more common data 
quality issues of accuracy and completeness.(35) 
3.4.3 Attitudes toward Secondary Use of EHR Data 
We had hypothesized that, to the extent clinical researchers were aware of EHR data 
quality problems, these concerns would be a barrier to secondary use.  There were a few findings 
in this area that were both important and surprising.  First, we had not anticipated the fact that 
every participant was at least somewhat concerned about EHR data quality.  This may have been 
partially a function of the fact that all participants were members of large medical center with a 
robust EHR system, and most had practiced clinically at the center.  Whatever the reason, the 
majority of the participants expressed conflicting beliefs about EHR data quality, and conflicting 
attitudes regarding the use of  EHR data in research.   
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The most important finding in this area is summarized by a quotation from one of the 
participants: “I mean, I think—starting at this point in time—it’s not even a question of positive 
or negative, because I think it’s the way of the future, or the way of the present.”  This sentiment 
was echoed, though not so explicitly, throughout the interviews.  Most participants were aware of 
EHR data quality problems, concerned about the validity of research conducted using EHR data, 
but nevertheless planned on using EHR data for research.  Our hypothesis, therefore, was only 
half right.  Concerns about EHR data quality existed, but were not a barrier to research.  If this 
attitude can be generalized to the broader population of clinical researchers, then it emphasizes 
the importance of and immediate need for the development of methodological approaches to the 
assessment and improvement of EHR data quality.  If secondary use is going to continue, it is 
important to make the research conducted using EHR data as trustworthy and as valid as possible. 
3.4.4 Involving Experts in the Secondary Use Process 
One point that many of the participants made is that an expert—either on the clinical 
topic of interest or the clinical workflows that generated the data—should be involved in the 
identification, validation, and analysis of EHR data for clinical research.  In our previous research 
we suggested that a systematic approach for EHR data quality assessment was necessary,(28) and 
other groups, particularly the Observational Medical Outcomes Partnership, are working not only 
systematic, but automated methods.(42, 43)  Our findings from the current study, however, 
suggest that clinical researchers desire a certain degree of human influence in the process of 
deciding how and if EHR data should be used in research.  They believe that clinicians have a 
better understanding of what the data are actually measuring, how they are recorded, and what 
they mean than someone who approaches the data as an outsider.  It may be that a “black box” 
approach to data quality assessment would have limited acceptance amongst clinical researchers.  
It is also possible that the participants were right, and that personal experience and clinical 
expertise is still vitally important in the reuse of EHR data, particularly as it relates to the data 
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quality assessment process.  Unfortunately, this kind of expert input has the potential to decrease 
the efficiency and the consistency of EHR data secondary use.  It may also pose a problem when 
researchers work with clinically-generated datasets that have been fully deidentified or drawn 
from multiple institutions, since in these scenarios it may no longer possible to draw conclusions 
about data quality based upon the provenance of the data (though the use of metadata could 
alleviate this problem). 
3.4.5 Possible Approaches to the Data Quality Problem 
Three primary approaches for handling the problem of questionable EHR data quality 
were mentioned during the interviews.  The first, and currently most common, is to assess and, if 
possible, “fix” the data after it has been collected.  Studies that involve the secondary use of EHR 
data take this approach when they involve the validation of the data or the imputation of missing 
values.  The advantage of this approach is that it does not interfere with the clinical workflows 
already in place in the data collection processes.  The disadvantage is that there are limited 
options for actually improving the data at this stage in the data lifecycle. 
A second option would be to introduce an intervention before the point of data extraction.  
This could mean changing clinical workflows or documentation practices.  Alternatively, the 
development and introduction of new EHRs and other health information technology systems that 
encourage good documentation and otherwise improve efficiency could improve the quality of 
the data collected.  Although some of the participants were hesitant to suggest that research 
should be a priority in clinical settings, most felt that clinical care itself is not enough of a priority 
(versus billing or administrative services), and that EHRs that embrace clinical workflows and 
patient care could only improve data quality. 
A final option would be to simply limit the types of research being conducted with EHR 
data.  Specifically, using EHR data only for preliminary research or hypothesis generation would 
mean that if the results are invalidated by data quality problems, this lack of validity will be 
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uncovered during further study using more controlled data.  Given the eagerness most of the 
participants expressed to use EHR data for research, however, this seems unlikely.   
3.4.6 Limitations and Future Work 
There are a number of limitations to this work, mostly centered around the lack of 
generalizability of our findings.  Our sample size was small and from only a single institution.  
Also, the majority of our sample had extensive experience using an EHR, either as clinicians or 
informaticians.  It is unclear whether the broader clinical researcher community would be as 
family with EHR data, or problems of EHR data quality.  Alternatively, it may be possible that 
individuals who are less familiar with EHRs would be less comfortable using EHR data in their 
research.  Ideally, this study should be repeated with a more representative sample of clinical 
researchers.  We plan to replicate this study in other institutions using a larger sample in the 
future.  
Another limitation is that we have no way to link the perceptions and attitudes of our 
participants to concrete behaviors.  In other words, do the views espoused during these interviews 
actually reflect participant behaviors as they relate to EHR data reuse and data quality 
assessment?  Would a participant who says the data should always be validated by a clinical 
domain expert actually secure the assistance of a domain expert when participating in the 
secondary use of EHR data?  Further work would be needed to determine how the predisposing, 
enabling, and reinforcing factors identified in this study actually impact the research process 
using EHR data. 
3.5 Conclusion 
 Our findings indicate that clinical researchers are aware of data quality issues, 
but that data quality issues are not a barrier to the secondary use of EHR data.  The major barriers 
and rewards for engaging in the secondary use of EHR data are largely unsurprising.  Improved 
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efficiency of research and publication were both seen as benefits, while issues like limited data 
accessibility and availability were identified as hindering the research process.  
Clinical researchers identified a number of potential causes of data quality problems, and 
were especially critical of EHRs themselves.  They also felt that EHR data quality was variable, 
and largely dependent upon the clinical variables and data types being used.  Most believed that 
domain experts should be involved in the process of validating EHR data prior to reuse, which 
indicates that a black box approach to EHR data quality assessment or the lack of transparency of 
EHR data quality may not be readily accepted by clinical researchers.  Future work on EHR data 
reuse and data quality assessment should take researcher perceptions and attitudes into account.  
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Chapter 4: The Task-Dependence of 
Electronic Health Record Data Quality1 
 
4.1 Introduction 
With the growing availability of large electronic health record (EHR) databases, clinical 
researchers are increasingly interested in the secondary use of clinical data.(1, 2) While the 
prospective collection of data is notoriously expensive and time-consuming, the use of an EHR 
may allow a medical institution to develop a clinical data repository containing extensive records 
for large numbers of patients, thereby enabling more efficient retrospective research. These data 
are a promising resource for comparative effectiveness research, outcomes research, 
epidemiology, drug surveillance, and public health research. 
1 This chapter was originally published in the Journal of Biomedical Informatics. The full citation for this 
publication is:  
Weiskopf NG, Hripcsak G, Swaminathan S, Weng C. Defining and measuring completeness of electronic 
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Unfortunately, EHR data are known to suffer from a variety of limitations and quality 
problems. The presence of incomplete records has been especially well documented.(3-6) The 
availability of an electronic record for a given patient does not mean that the record contains 
sufficient information for a given research task.  
Data completeness has been explored in some depth. The statistics community has 
focused extensively on determining in what manner data are missing. Specifically, data may be 
considered to be missing at random, missing completely at random, or missing not at random.(7, 
8) Datasets that meet these descriptions require different methods of imputation and inference. 
The statistical view of missing or incomplete data, however, is not sufficient for 
capturing the complexities of EHR data. EHR records are different from research data in their 
methods of collection, storage, and structure. A clinical record is likely to contain extensive 
narrative text, redundancies (i.e., the same information is recorded in multiple places within a 
record), and complex longitudinal information. While traditional research datasets may suffer 
from some degree of incompleteness, they are unlikely to reflect the broad systematic biases that 
can be introduced by the clinical care process.  
There are several dimensions to EHR data completeness. First, the object of interest can 
be seen as the patient or as the health care process through which the patient was treated; there is 
a difference between complete information about the patient versus complete information about 
the patient's encounters. A patient with no health care encounters and an empty record has a 
complete record with respect to the health care process, but a blank one with respect to the 
patient. Furthermore, one can measure completeness at different granularities: the record as a 
whole or of logical components of the record, each of which may have its own requirements or 
expectations (e.g., demographic patient information versus the physician thought process). (9, 10)  
Another dimension of completeness emerges from the distinction between intrinsic and extrinsic 
data requirements. One can imagine defining minimum information requirements necessary to 
consider a record complete (which could be with respect to either the patient or the health care 
78 
 
  Chapter 4: Task Dependence 
process), or one can tailor the measurement of completeness to the intended use. Put another way, 
we can see completeness in terms of intrinsic expectations (i.e., based a priori upon the content) 
or extrinsic requirements (based upon the use). (11, 12)   
The EHR data consumers who define these extrinsic requirements will have different data 
needs, which will in turn dictate different conceptualizations of a complete patient record. Here, 
Juran’s definition of quality becomes valuable: “fitness for use.”(12) It may be that data 
completeness does not have a simple, objective definition, but is instead task-dependent. Wang 
and Strong, for example, in their work developing a model of data quality, define completeness as 
“[t]he extent to which data are of sufficient breadth, depth, and scope for the task at hand.”(13) In 
other words, whether a dataset is complete or not depends upon that dataset’s intended use or 
desired characteristics. In order to determine the number of complete records available for 
analysis one must first determine what it means to have a complete patient record. The quality of 
a dataset can only be assessed once the data quality features of interest have been identified and 
the concept of data quality itself has been defined.(11) 
Multiple interpretations of EHR completeness, in turn, may result in different subsets of 
records that are determined to be complete. The relationships between research task, 
completeness definition, and completeness findings, however, are rarely made explicit. Hogan 
and Wagner offer one of the most widely used definitions: “the proportion of observations that 
are actually recorded in the system.”(5) This definition does not, however, offer specific measures 
for determining whether a record is complete. Neither does it account for the possibility that 
completeness may be task-dependent. What proportion of observations should be present? Which 
observations are desired? Are there any other considerations beyond simple proportion? 
Furthermore, observations are complex, nested concepts, and it must be determined what level of 
detail or granularity is needed or expected. In order of increasing detail, one could record a visit 
that occurred, the diagnoses, all the symptoms, a detailed accounting of the timing of all the 
symptoms, the clinician’s thought process in making a diagnosis, etc.  
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In the sections below, we enumerate four specific operational and measurable definitions 
of completeness. These definitions are not exhaustive, but they illustrate the diversity of possible 
meanings of EHR data completeness. We ran the definitions against our clinical database in order 
to demonstrate the magnitude of completeness in the database and to illustrate the degree of 
overlap among the definitions. 
4.2 Methods 
Previously, we conducted a systematic review of the literature on EHR data quality in 
which we identified five dimensions of data quality that are of interest to clinical researchers 
engaged in the secondary use of EHR data. Completeness was the most commonly assessed 
dimension of data quality in the set of articles we reviewed.(3) Based upon this exploration of the 
literature on EHR data quality, consideration of potential EHR data reuse scenarios, and 
discussion with stakeholders and domain experts, we describe four prototypical definitions of 
completeness that represent a conceptual model of EHR completeness. Further definitions of 
completeness are possible and may become apparent as the reuse of EHR data becomes more 
common and more use cases and user needs are identified. 
Figure 1 presents a visual model of the four definitions of completeness, which are 
described further in section 2.1. In this model of EHR data, every potential data point represents 
some aspect of the patient state at a specific time that may be observed or unobserved as well as 
recorded or unrecorded. The longitudinal patient course, therefore, can be represented as a series 
of points over time that may or may not appear in the EHR.  
4.2.1 Definitions 
Documentation: A record contains all observations made about a patient  
The most basic definition of a complete patient record described in the literature is one 
where all observations made during a clinical encounter are recorded.(5) This is an objective, 
task-independent view of completeness that is, in essence, a measure of the fidelity of the 
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documentation process. Assessments of documentation completeness rely upon the presence of a 
reference standard, which may be drawn from contacting the treating physician (14), observations 
of the clinical encounter,(15) or comparing the EHR data to an alternate trusted data source—
often a concurrently maintained paper record.(16-19) Documentation completeness is also 
relevant to the quality measurements employed by the Centers for Medicare & Medicaid 
Services.(20)  
In secondary use cases, however, the data consumer may be uninterested in the 
documentation process. Instead, completeness is determined according to how well the available 
data match the specific requirements of the task at hand, meaning that completeness in these 
situations is more often subjective and task-dependent. While documentation completeness is 
intrinsic, the following three definitions of completeness are extrinsic and can only be applied 
once a research task has been identified. 
Breadth: A record contains all desired types of data 
Some secondary use scenarios require the availability of multiple types of data.  EHR-
based cohort identification and phenotyping, for example, often utilize some combination of 
diagnoses, laboratory results, medications, and procedure codes.(21-23) Quality of care and 
clinician performance assessment also rely upon the presence of multiple data types within the 
EHR (the relevant data types vary depending upon clinical area).(20, 24-27) More broadly, 
researchers interested in clinical outcomes may require more than one type of data to properly 
capture the clinical state of patients.(28, 29) In the above cases, therefore, a complete record may 
be one where a breadth of desired data types is present. It is important to note that the absence of 
a desired data type in a record does not necessarily indicate a failure in the clinical care process or 
in the recording process. Rather, it may be that a data type that is desired for research was not 
relevant from a clinical standpoint, and therefore was not observed. 
Density: A record contains a specified number or frequency of data points over time 
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In many secondary use scenarios, EHR data consumers require not only a breadth of data 
types, but also sufficient numbers and density of data points over time.(30) Some of the 
phenotyping algorithms developed by the eMERGE Network, for example, rely upon the 
presence of multiple instances of the same laboratory tests, diagnoses, or medications,(31) and 
sometimes specify desired time periods between the recording of these data within the EHR.(32, 
33)  Clinical trial eligibility criteria, which can be compared to patient records to identify relevant 
cohorts, also contain complex temporal data specifications,(34) as do EHR data requests 
submitted by clinical researchers.(35) Breadth and density can be considered complementary, 
orthogonal dimensions of completeness. A single point of patient data, for example, has breadth 
and density of one. 
Predictive: A record contains sufficient information to predict a phenomenon of interest 
Our final and most complex definition of EHR data completeness arises when one 
considers that the overall goal of much research is the ability to predict an outcome(13).  It is 
possible to train various computational models, some of which being more tolerant of missing 
data than others, using EHR-derived datasets.  Researchers may be interested in predicting, 
amongst other clinical phenomena, disease status and risk,(36-38) readmission,(39, 40) or 
mortality.(41, 42)  Depending upon the model employed, data needs may be implicit, rather than 
explicit.  The metric for completeness is performance on the task, rather than counts of data 
points. The data that are required are those that are sufficient to make a prediction. Therefore, it 
may that two records with different data profiles are both complete according to this definition.   
4.2.2 Data 
NewYork-Presbyterian Hospital (NYPH) is a not-for-profit hospital in New York City 
consisting of five locations. For the purposes of this research, we included data from: the Milstein 
Hospital, a tertiary care hospital, and its associated ambulatory areas; Allen Hospital, a 
community hospital; and Morgan Stanley Children’s Hospital. All are in upper Manhattan. These 
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locations and their affiliated offices treat close to 300,000 unique patients per year. The patient 
population is 56% female, with an average age of 51 years. The population is 32% Hispanic, 10% 
Asian, 19% Black, and 39% White.  
A number of different health information technology systems are in place at NYPH. In 
this study, we used data from Allscripts’s Sunrise Clinical Manager for clinical care, Cerner 
Millennium for ancillary services, and Eagle Registration for administrative transactions. 
4.2.3 Experiments 
Four experiments were designed to demonstrate applications of each of the above 
definitions to EHR data. A fifth experiment was used to compare the datasets deemed complete 
according to each of the four definitions. We sampled representative data types for each 
definition. Specifically, we selected data types that are expected to be present in most EHRs, and 
which are commonly required in research use cases. These data types include, but are not limited 
to, admission and discharge information, laboratory results, medication orders, and basic 
demographic information. Each day a patient was present in the hospital or an affiliated medical 
office represents an opportunity to observe and record data on the patient state. Each data 
observation and recording opportunity, in turn, includes multiple data types (e.g., diagnosis, 
laboratory result, etc.).  
EHR completeness can be measured at different levels of granularity. One might 
examine, for example, the completeness of a full patient record (e.g. each patient represents a 
potential subject or case), or of specific data types (e.g., lab values are extracted and aggregated 
across patients). It can also be argued that at any granularity, EHR data never have total 
completeness.  For the purposes of this demonstration, however, we have chosen to measure 
completeness at the patient record level, and have categorized records as either complete or 
incomplete according to each definition of completeness. Completeness according to each 
definition, therefore, is reported in number of patient records that meet the relevant criteria. 
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Rather than provide generalizable completeness findings for EHR data, our goal is to explicitly 
define and measure completeness from various perspectives and to illustrate the misalignment 
and intersections among different definitions of completeness. 
4.2.3.1 Documentation 
If a complete record must contain all information that was gathered during a clinical 
encounter—a potential data collection point-- a record is incomplete if there was a failure in the 
recording process. Determining when there was a failure to record data, however, is difficult 
without a reference standard. NYPH policy dictates that every day that a patient is present in the 
hospital or one of its affiliated offices, a narrative note should be entered into their record. 
Therefore, to illustrate this definition, we considered a record without a note on any day that a 
patient was present for treatment to be incomplete. Inherent in this approach is the assumption 
that visits are themselves appropriately recorded. 
We extracted visit data on all patients in the NYPH clinical data warehouse and 
determined on which days they were present. Each day was considered to be a potential data 
collection point. We then identified all days where a patient had a narrative note or report 
recorded. Every day a patient was present without an associated note or report was said to be a 
data point that did not meet the definition of documentation completeness.  
4.2.3.2 Breadth 
When researchers require a breadth of information about patients, a record is considered 
complete if certain desired types of information are present. The information required for a record 
to be deemed complete will vary according to the research task at hand. For this experiment, we 
chose to look for the presence of five data types frequently found in patient records: laboratory 
results, medication orders, diagnoses, sex, and date of birth. In this example, a patient with all 
five data types present would be said to have a complete record. Given the multiplicity of 
laboratory tests, we also looked specifically at two common laboratory results: blood glucose and 
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hemoglobin measurements. For all patients, we measured the coverage of laboratory results, 
medication orders, and diagnoses for each day that they were present in the hospital or an 
affiliated office. The presence of sex and date of birth were assessed once for each patient. 
4.2.3.3 Density 
Some research tasks require the availability of multiple data points over time. Moreover, 
these data points may be required with some degree of regularity or covering a desired period of 
time. A complete record, therefore, would be one with a desired number of data points over a set 
period of time, spaced at sufficiently even intervals. For this experiment, we looked at the 
quantity and temporal distribution of patient visits, medication orders, and laboratory results. We 
approached this view of completeness in two ways. First, we looked at the number of clinical data 
points over the course of a patient record. Second, we applied an adjustment described by Sperrin 
et al. that accounts for the temporal irregularity of data.(30)  
where 
 
I gives the average amount of information provided by each data point by accounting for 
the variability between those points. In the ideal situation, where all points are evenly spaced, I = 
1. Multiplying I by n gives the number of effective data points. Sperrin et al. also proposed a 
linear adjustment that may be used to determine not only how evenly spaced data are, but to what 
extent a period of interest is covered by those data points. A set of points evenly spaced over a 
month may give sufficient information about that month, but if the period of interest is a full year, 
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4.2.3.4 Predictive 
One goal of reusing EHR data is to predict something or to find associations. Therefore, a 
record that contains sufficient information to predict successfully can be considered to be 
sufficiently complete for the stated purpose. We illustrated the definition for predictive 
completeness by assessing our ability to predict return visits. Such prediction is important in the 
context of health care reform, because institutions are striving to reduce readmission rates, and 
predicting who is likely to return allows institutions to target resources to prevent readmissions. 
We employed a logistic regression model using type and number of visits, number of 
medications, and number and value of common laboratory tests as the independent variables and 
using the presence of a gap of 180 days or more in future visits as the dependent variable. 
4.2.3.5 Comparison of Completeness Definition Results 
Further analysis was performed in order to compare records considered to be complete 
according to the four definitions of completeness. A documentation complete record was one with 
at least one visit accompanied by a narrative note. Records with breadth completeness were those 
that included a patient’s date of birth, sex, and at least one medication order, laboratory test, and 
diagnosis. For density, we considered the presence of medication orders and laboratory tests over 
time, since these data types represent common clinical actions. Temporal resolution was 
considered down to the second. Sperrin’s I was used to calculate the number of effective data 
points. Finally, we determined the predictive completeness of records using a simplified version 
of the logistic regression model described in section 2.3.4. The dependent variable was a gap in 
each patient record of at least 180 days, and the independent variables were counts of medication 
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4.3 Results 
4.3.1 Documentation Completeness 
Of the approximately 3.9 million patients with data in the clinical data warehouse, 48.3% 
have at least one visit recorded where a free-text note or report would be expected. Due to the 
gradual process of EHR adoption within NYPH, the percentage of missing notes has dropped 
drastically over the years (Figure 2). The overall rates of non-missing notes compared to the rates 
of visits are shown in Figure 3. Of all the patients with data in the clinical data warehouse, 18.5% 
have at least one visit with an associated note or report, 7.1% have five or more, and 4% have ten 
or more. Since 1986, 23.6% of all recorded visits have been accompanied by notes or reports. 
Over the most recent calendar year, however, the rate of completeness according to this definition 
has been significantly higher: 98.6% of inpatient visits, 73.8% of outpatient visits, and 95.0% of 
emergency visits have same day notes or reports recorded.  
 
Figure 4.1 Documentation completeness over time. The documentation completeness of records has 
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Figure 4.2 Documentation completeness. Shows the number of patients who have been present in the hospital for 
a certain number of days, as well as the number of patients whose records have notes associated with a certain 
number of days that they have been present. 
4.3.2 Breadth 
Of the patients with data in the clinical data warehouse, 29.3% had at least one visit with 
a recorded laboratory result (20.0% glucose, 23.0% hemoglobin), 12.6% had at least one with a 
medication order, and 44.5% had at least one with a diagnosis. The vast majority of patient 
records included basic demographic information: 97.8% had a valid date of birth recorded, and 
99.6% had sex recorded. 
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Figure 4.3 Breadth completeness. The number of patients with laboratory results, medication orders, and 
diagnoses on the same day as compared to the number of days when they were present in the hospital. Below, 
the number of patients with zero, one, two, or all of these data types present in their record on the same day. 
 
Figure 4 shows the rates of visits with associated medications, laboratory tests, and 
diagnoses, as well as the rates of visits with none, one, two, or all three types of information. Of 
the patients with records in the clinical data warehouse, 10.4% had at least one visit with all three 
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Figure 4.4 Density completeness of records. The number of patients with a given number of days with 
recorded visit events, laboratory results, or medication orders. The raw number of days, the number of days 
adjusted for variance, and the number of days adjusted for variance and time period are shown. 
 
4.3.3 Density 
Overall, 55.4% of the patients with records in the clinical data warehouse had at least one 
day with a recorded admission event, discharge event, laboratory result, or medication order. 
Twenty-three point eight percent had at least five, and 15.6% had at least ten. With Sperrin’s I 
applied, 16.6% had at least five, and 10.4% had at least ten. With Sperrin’s I and the linear 
adjustment, these figures dropped even further: 13.6% had at least one, 6.5% had at least five, and 
4.4% had at least ten. If the time span of interest is limited to the year in which each patient spent 
the most days at the hospital, the rates of raw visits and effective visits meeting criteria are lower, 
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but the rates of adjusted visits are higher. Figure 5 shows the rates of raw, effective, and adjusted 
counts of days that patients were present in the hospital. 
4.3.4 Predictive 
We were able to predict 180-day-or-greater gaps in visits and data with an accuracy of 
0.89. The area under the receiver operating characteristic curve was 0.79. The nature of the visits 
and duration of the records were predictive of gaps. Based upon this conceptualization of 
completeness, unlike breadth or density completeness, individual cases are predicted either 
correctly or incorrectly, so there is no sense of an intermediate completeness on an individual 
case. 
4.3.5 Comparison of Completeness Definition Results 
A comparison of the records satisfying the breadth, density, documentation, and 
predictive definitions of completeness is shown in Figure 6.(43) Overall, 55.7% of patients in the 
CDW have at least one point of clinical data, and 26.9% meet the criteria for at least one 
definition of completeness. In terms of density, only 11.8% have a complete record when 
completeness is defined as at least 15 laboratory results or medication orders adjusted for 
temporal variance. When completeness is defined as a breadth of five data types of interest (date 
of birth, sex, medication order, laboratory test, and diagnosis), 11.4% of patients have complete 
records. Patients with documentation complete records —meaning they had at least one visit with 
an associated note-- accounted for 18.5% of all patients. Finally, the presence or absence of a gap 
of 180 days or more could be correctly predicted for 8.4% of patients. Only 0.6% of patient 
records could be considered complete according to the implementations of all four definitions. 
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Figure 4.5 Comparison of completeness definition results. Subsets of patients with complete records 
according to the density (medication orders and laboratory tests over time with Sperrin’s adjustment), breadth 
(record includes date of birth, sex, and at least one medication order, laboratory test, and diagnosis), 
documentation (at least one visit accompanied by a note), and predictive (a gap of 180 days can be correctly 
predicted) completeness definitions. 
4.4 Discussion 
At the time of this study, the clinical data warehouse contained the electronic records of 
approximately 3.9 million patients, but the number of records with sufficient information for 
various analyses is likely much lower. Only about half would be considered complete according 
to any of the four definitions using the least stringent cutoffs (e.g., at least one data point, at least 
one visit, or at least one medication or laboratory result). Only about a quarter would be 
considered complete with more detailed data requirements (e.g., at least one visit with an 
associated note or laboratory result, at least five visits over the course of a record). When limited 
not only to complete records, but also to a relevant cohort, the amount of useful information will 
drop even further. By any definition only a fraction of all the records are complete and suitable 
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Moreover, the number of records in the relevant dataset varies depending upon the 
definition of completeness being used, which is in turn dependent upon user needs. Someone who 
is interested in patient care or outcomes over the longitudinal patient record will require very 
different data from someone looking at a cross-section of a patient population or someone 
studying the quality of care delivered at a medical institution. These users might identify 
complete records through, respectively, the density, breadth, and documentation completeness 
definitions described in this paper. As we have shown, each of these definitions results in a 
different number of complete records. Before making a determination of how many complete 
records are available for analysis, therefore, a researcher should first determine and specify what 
their data needs are, and then select the appropriate definition of completeness and provide it 
together with the completeness analysis result.  
Further complicating the issue of completeness is the fact that not only do different 
definitions of completeness result in different numbers of useable records, these definitions may 
also point to different sets of relevant records. One might expect that a record that satisfies one 
definition of completeness is likely to satisfy another, but this is not necessarily the case. As 
shown in the comparison of the four definitions of completeness, the resulting sets of useable 
records share only partial overlap (Figure 6). In this study, documentation completeness suggests 
breadth or density completeness, possibly because our method of determining documentation 
completeness (section 2.3.1) requires the presence of at least one recorded visit. Predictive 
completeness, on the other hand, has little overlap with the other three result sets. Although 
26.9% of the records in our CDW meet the criteria for at least one of the definitions of 
completeness, only 0.6% meet the criteria for all four. Therefore, explicitly selecting a relevant 
definition of EHR completeness is necessary to identify not only how many records are complete, 
but also which records are complete. 
It is important to note that a range of defined completeness is possible and will depend in 
part upon the complexity of the task for which the data will be used. Taking a trivial example 
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based on the concept of predictive completeness, predicting the patient’s age next year requires 
only the current age, implying most of the patients’ records are complete, but predicting the age at 
which a patient will die is very difficult. Patients with rapidly fatal diseases may be predicted 
from their diagnoses, but others would be more difficult. Similarly, simple research tasks are 
likely to require less breadth or density of data than more complex tasks. 
There may be analytic ways to address or avoid incompleteness. For example, the 
algorithm to predict gaps could be used to decide if an individual record is complete. If a patient 
has a gap and a gap was predicted from preceding data, then perhaps the gap was real; for 
example, the patient may have been healthy during the period. If, however, the patient has a gap 
and a gap was not predicted, then perhaps some data are missing. For example, perhaps the 
patient did have visits but the patient went to a different health provider. Thus the prediction may 
indicate the likelihood of completeness in the sense of the first definition (i.e., were the data that 
should have been there present). One could then potentially filter out cases with apparently 
missing visits. 
4.4.1 Limitations 
The rates of complete records identified in this study are not generalizable to other 
institutions. Differences in populations served, settings, workflows, HIT, and data procedures 
result in unique data profiles. The definitions of completeness described in this study, however, 
are not specific to our institution. The idea that information quantity can only be determined 
following the identification of a relevant definition of EHR completeness and the selection of an 
appropriate method of measurement is generalizable.  
The definitions of completeness described in this study are primarily illustrative and are 
not exhaustive, as we may have failed to take into account all the needs of potential data 
consumers. We did not study, for example, the relationship between record completeness and 
underlying patient status. That is, a healthy patient’s record would be expected to look very 
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different from a sick patient’s. Further work is needed to more thoroughly and rigorously model 
the concept of completeness as it relates to the secondary use of EHR data. 
The four definitions of completeness described in this study also require further 
exploration. In the case of predictive completeness, for example, it is unclear how to interpret the 
result: what level of prediction is sufficient to consider the EHR to be complete? Complicating 
this is the difficulty distinguishing the cause of low predictive accuracy. It could be because of 
lack of data, tackling a problem that is hard to solve, or the difficulty of developing an 
appropriate model.  
Finally, completeness is closely tied to other dimensions of data quality. In examining 
completeness, we made no assumptions regarding the correctness of the data. The fact that data 
are present does not mean that they are necessarily trustworthy. A full assessment of an EHR-
derived dataset prior to reuse should go beyond completeness.  
4.5 Conclusion 
We have illustrated that multiple definitions of completeness may be used, that they lead 
to different degrees of measured completeness for the same dataset, and that the number of 
complete records in a typical clinical database may be far lower than the nominal total. As 
researchers and clinicians continue the trend of repurposing EHR data for secondary use, it is 
important to bear in mind that these clinical data may not satisfy completeness requirements. 
Completeness, however, is contextual and is determined through an understanding of specific 
data needs. The number of complete records available for analysis is dependent upon the 
definition of completeness being used. Each definition results in a different set of complete 
records. We urge EHR data consumers to be mindful of the potential limitations of a dataset prior 
to committing to its use, explicit in their choice of completeness definition, and transparent about 
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  Chapter 5: Sampling Bias 
Chapter 5: Sufficient Electronic Health 
Record Data and Potential Sampling Bias1 
5.1 Introduction 
There is great promise in the reuse of electronic health record (EHR) data for clinical 
research purposes. Retrospective research that reuses existing datasets is generally faster and less 
costly than prospective research. EHR data have the added benefit of being representative of 
actual healthcare consumers. For these reasons, amongst others, there is growing interest in the 
secondary use of EHR data.(1-3)  
When working with EHR data, however, it is important to be mindful of potential data 
quality caveats.(4) A number of studies have established that poor data quality may challenge the 
1 The majority of this chapter was originally published in the 2013 AMIA Annual Proceedings.  Nicole 
Weiskopf and Alex Rusanov were listed as equally contributing first authors.  The full citation for this 
publication is:  
Weiskopf NG, Rusanov A, Weng C: Sick patients have more data: the non-random completeness of 
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suitability of EHR data for research.(5-7) In our previous work, we identified three core 
dimensions of data quality in which researchers engaged in the secondary use of EHR data are 
interested: completeness, correctness, and currency.(8) We further illustrated that EHR data 
completeness is a task-dependent phenomenon, and that how record completeness is defined 
depends upon the intended use for the data.(9)  
EHR data completeness may be understood differently in the clinical setting versus in the 
research setting.  Clinically, completeness is most commonly understood to mean fidelity of 
documentation.(6)  In other words, a record is considered complete if it contains all information 
that was observed.  When repurposed for secondary use, however, the concept of “fitness for use” 
can be applied.(10, 11)  In secondary use settings, EHR data completeness becomes extrinsic, and 
is dependent upon whether or not there are sufficient types and quantities of data to perform a 
research task of interest. It should be noted that a record deemed incomplete for a given research 
use might be complete from a clinical standpoint. As an example, the clinical requirement for 
frequency of blood pressure and heart rate measurement during provision of anesthetic care is 
every five minutes.(12) A record documenting these two variables at five-minute intervals would 
thus be complete from a clinical standpoint. A researcher, however, might be interested in beat-
to-beat variations. A record documenting these variables at five-minute intervals would thus be 
incomplete from a research standpoint. Similarly, the record would also be incomplete if a 
researcher was interested in pulmonary artery pressures and these were not documented. 
When considering the problem of incomplete data, it is important to understand the 
manner in which data are incomplete. In statistics, data are understood to be missing at random or 
missing not at random.(13, 14) When incompleteness is a random phenomenon, the signal may 
become noisier, but is otherwise unchanged. Non-random incompleteness, however, may 
introduce a spurious signal into a dataset. Therefore, it is important to understand not only how 
much data is missing, but also if those data are missing according to a certain pattern that might 
have clinical relevance. The same could be said of correctness as well: random error is less 
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problematic than systematic error. Similarly, consider data currency: if a random subset of the 
data are out of date it is less likely to cause a problem than if, for example, only data from less 
healthy patients are out of date. When engaged in the secondary use of EHR data for research, it 
is important to know whether the records identified as complete for a given research task are 
representative of all patients of interest, or if the act of selecting for completeness actually results 
in a non-representative group of records. The literature on this topic is limited.  
Researchers who use EHR-derived data often apply implicit data quality requirements to 
their datasets. In selecting a cohort for study, eligibility criteria often include requirements that 
patients have at least x number of laboratory values, or have been followed for y number of 
months, or that they must have records containing y different points of data over time. The 
implication of these criteria is that to be eligible a patient must have a record that meets a certain 
level of data quality, specifically completeness in these examples. In the future, researchers may 
even have explicit criteria for record inclusion. Perhaps all records included will need to be free 
from detectable error. Any type of cohort restriction, however, introduces the possibility of 
selection bias. If a study only included patients under the age of twenty, the researchers would 
likely acknowledge that the results might not be generalizable to older adults. But what does it 
mean to say that the results of a study cannot be generalized to patients with less complete 
records? Is there a clinically meaningful difference between patients with good quality data and 
those with worse quality data?  
In the study reported here, we hypothesize the existence of a relationship between record 
completeness and the underlying health status of the patient of interest. Through the use of 
representative data types and a broadly applicable definition of complete EHR data, our study 
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5.2 Methods 
5.2.1 Identification of a Health Status Indicator 
In order to look at the relationship between patient health and record completeness from 
the secondary use perspective, we required the use of a reliable measure of health status that does 
not rely entirely on the presence of these data types in the record. The American Society of 
Anesthesiology (ASA) Physical Classification score(15, 16) is a subjective assessment of overall 
health or illness severity assigned by an anesthesia provider to every patient requiring anesthetic 
services. The ASA score is based not only on information present in the EHR but also on 
interviews with the patient, family and the patient’s other healthcare providers well as 
information (i.e. laboratory results, imaging and other diagnostic testing results, medical records, 
prescriptions, etc.) from sources outside the institution and thus not present in the EHR. It is a 
severity of illness score that is prospectively assigned to each patient by a scoring expert 
(anesthesia provider) and is thus much less reliant on EHR data than retrospectively assigned 
scores (e.g Charlson Comorbidity Index) which rely solely on information present in the EHR. 
We also sought a measure that is routinely recorded for a broad spectrum of the patient 
population, as opposed to those that focus on a specific disease (e.g., New York Functional Status 
Classification for heart failure patients) or segment of the population (e.g., children). The score 
separates patients into one of six categories (Table 1), with the letter “E” appended for emergency 
procedures, and has been shown to be strongly correlated with other clinical risk predictors(17) as 
well as outcomes.(18-20) Although the requirement of an ASA score limits our cohort to those 
who have received anesthesia, we felt that it allowed us to capture a more broad population than 
the other illness measures and have an severity of index measure that was mostly independent of 
presence of data in the EHR.   
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5.2.2 Data 
Table 5.1 . American Society of Anesthesiology (ASA) Physical Status Classification. 
ASA Class Definition 
   1 
   2 
   3 
   4 
   5 
   6 
A normal healthy patient 
A patient with mild systemic disease 
A patient with severe systemic disease 
A patient with severe systemic disease that is a constant threat to life 
A moribund patient who is not expected to survive without the operation 
A declared brain-dead patient whose organs are being removed for donor 
purposes 
  
The Columbia University Department of Anesthesiology provides anesthetic services for 
operating rooms at three hospitals – a tertiary-care academic medical center (Milstein), a 
dedicated children’s hospital (CHONY) and a small community hospital (Allen). Additionally, 
anesthetic services are also provided for the labor and delivery floors at CHONY and Allen as 
well as several “off-site” locations such as endoscopy, radiology, neuroradiology, cystoscopy, 
cardiac catherization and electrophysiology suites, and ophthalmologic surgery suites. For the 
majority of patients for whom we provide anesthetic services an anesthesia information 
management system, CompuRecord (Philips Healthcare, Andover, MA) is used for electronic 
recordkeeping. The ASA Class score is recorded for all valid procedures. The data collected by 
this system is periodically migrated to a research database, with the last update occurring in 
October 2012.  
The Columbia University Medical Center Institute Review Board approved this study. 
We began by identifying all patients in the CompuRecord research database with a recorded ICD-
9 and CPT code.  These codes have been recorded in the database since April 2012, so we 
identified patients with anesthesia procedures recorded between April, 2012 and the end of 
September, 2012. To minimize bias introduced by having multiple procedures requiring 
anesthesia within our time period of interest (one year preceding the procedure), we focused only 
on the earliest procedure for each patient in our dataset and then excluded all patients who had a 
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procedure in the preceding year, or who were less than one year of age at the time of the 
procedure. From the remaining set of patients we pulled the ASA Class for a randomly selected 
set of 5000 patients for the current analysis. Due to the infrequent occurrence of ASA Classes 5 
and 6 we dropped the patients in these classes from our analyses. 
For demonstration purposes, we selected two common clinical data types through which 
to assess record completeness: laboratory results and medication orders. Because we did not have 
a specific use case in mind, we did not use a hard cut-off for defining a complete record. Instead, 
we assumed that each record existed on a continuum of less or more complete, as implied by 
counts of days where data were present. The raw counts of days with medication orders and days 
with laboratory results were calculated for each of the 5,000 patients during the year preceding 
their procedures using data obtained from the Clinical Data Warehouse (CDW). These data are 
drawn from a combination of Allscripts’s Sunrise Clinical Manager for clinical care and Cerner 
Millennium for ancillary services. 
5.2.3 Data Analysis Methods 
We compared the completeness of records between ASA Classes for both data types 
using the Kruskal-Wallis one-way analysis of variance. Further post-hoc analyses were performed 
using the Wilcoxon rank-sum test with a Bonferroni correction. 
5.3 Results 
The average age of patients in our sample at the time of surgery was 45 with a standard 
deviation of 24 years, and 61% were female. The ASA Class distribution for our sample is 
summarized in Figure 1.  
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Figure 5.1 Distribution of ASA Class in study population. 
 
Figure 5.2 Record completeness, per ASA class, over a range of cutoffs (1-60), where cutoffs are the minimum 
number of values required in each of two categories (medication orders and laboratory results) to make a record 
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Figure 5.3 Magnified view of record completeness, per ASA class, over a range of cutoffs (1-15), where cutoffs 
are the minimum number of values required in each of two categories (medication orders and laboratory 
results) to make a record complete. 
 
We defined as complete any record having at least N recorded values in each of the two 
categories (medication orders and laboratory results), where N is the cutoff value, in days. Using 
this definition, the ratio of complete records over total records in each ASA Class was plotted as 
N was varied from 1 to 60 days (Figure 2). A magnified view of the plot is shown (Figure 3) to 
facilitate visualization by improving resolution in the range where N is between 1 and 15. As a 
specific example, we show the distribution of the proportion of records that are complete across 
ASA Classes given an arbitrary cut-off of N=7 (Figure 4). As the cutoff of number of desired 
points increases, the distribution of patients skews further towards the records of patients with an 
ASA status of 3 or 4. 
The average number of days with data for patients in each ASA Class are shown for 
medication orders and laboratory results in Figure 5.  Patients with a more severe health status 
have a higher number of days with data, on average. A Kruskal-Wallice one-way analysis of 
variance revealed a significant effect of ASA Class on number of days with medication orders 
(x2(3)=332.0, p<0.0001) and on number of days with laboratory results (x2(3)=202.2, p<0.0001). 
Post-hoc analysis using a Wilcoxon rank sum test with Bonferroni correction showed significant 
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differences between all ASA Classes except Class 1 and Class 2 for both data types, all with p-
values <0.0001. 
 
Figure 5.4 Complete records by ASA Class where complete records are those having at least seven 
values in each of the two categories (medication orders and laboratory results). 
 
 
Figure 5.5 Average number of days with data per patient by ASA class.  For both medication orders 
and laboratory results, all ASA Classes are significantly different except for Classes 1 and 2. 
 
5.4 Discussion 
The results indicate that our hypothesis that there is a relationship between patient health 
status and EHR completeness is correct. EHR data are not missing at random. Both medication 
orders and laboratory results show a significant increase in data points per patient as ASA Class 
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increases. Moreover, as the cutoff for what constitutes a complete record increases, the proportion 
of records considered complete concentrates towards the patients in higher ASA Classes. 
This indicates that a sample of patients naively drawn from the EHR-- assuming the 
records chosen are limited to those with sufficient data to be considered complete for the task at 
hand-- will almost invariably be biased towards sicker patients. In other words, those patients 
with records deemed complete for a given study are unlikely to be representative of the 
population of interest. These findings are in line with previous work exploring the complex 
relationships among data quality, bias, and health status.  In one example, Wennberg et al. used 
insurance claims data to demonstrate bias in comorbidity measurement by showing that Charlson 
Comorbity Index scores are associated with the frequency of physician visits,{Wennberg, 2013 
#231} suggesting that data quality is compromised by differences in healthcare utilization.  
Similarly, Collins et al. identified a relationship between patient mortality and increased rates of 
nursing documentation, suggesting that more acutely ill patients are likely to have more 
thoroughly documented records.{Collins, 2013 #236;Collins, 2012 #237} In a study of a 
pneumonia severity index based upon EHR data, Hripcsak et al. found that the addition of cohort 
selection criteria that required the presence of sufficient data to make a reliable diagnosis 
substantially limited sample size and significantly altered mortality rates.{Hripcsak, 2011 #423} 
They note that the addition of simple sample restraints, while beneficial in their case, has the 
potential to significantly narrow the sample, leading to the possibility of bias. At least in the case 
of completeness, data quality problems introduce not only noise into EHR data, but bias as well. 
A secondary finding suggested by our results is that data consumers may have a difficult 
time identifying healthy patients with sufficient data for secondary use. This is problematic for 
those seeking healthy controls or comparison cohorts for research purposes. 
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5.4.1 Limitations  
Because of the reliance of our analysis on the presence of ASA Class for all patients in 
our sample, only anesthesia patients were included in this study.  These patients may not be 
representative of the overall population with data in the CDW. By extension, the CDW itself may 
not be representative of typical EHR databases due to the tertiary academic medical setting. 
Nevertheless, we believe that the essential concept proven by this study—that there is a 
relationship between record completeness and patient health—will hold true across a broad range 
of clinical database and institutions. 
5.4.2 Future Directions 
We intend to continue this research by investigating factors that might be driving the 
observed trend. For example, we could consider the procedure performed, the diagnosis, the 
emergency status of the surgery, or inpatient/outpatient status prior to surgery. All are potential 
confounders.  
It would also be helpful to focus on special populations, such as children or pregnant 
women. One might expect, for example, that pregnant women would be mostly ASA Classes 1 
and 2, but with good chart completeness prior to their anesthetic due to pre-natal care. These 
special populations may require further consideration. 
Finally, we hope in the future to identify or develop methodological approaches to 
selecting complete patient records from EHR databases while avoiding the introduction of bias in 
the form of patient health status. 
5.5 Conclusion 
In this sample of 5,000 patients the percentage of complete records varied with ASA 
Class. This relationship held true for laboratory result and medication order data. Using ASA 
Class as a surrogate for patient health, the data confirm our initial hypothesis that there exists a 
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statistically significant difference between the completeness of electronic health records for sick 
patients and the completeness of electronic health records for healthy patients. Sicker patients 
tend to have more complete records and healthier patients tend to have records that are less 
complete.  
These results should serve as a word of caution to researchers wishing to use EHR data 
for research. Investigators wishing to reuse EHR data must be aware that blind sampling of 
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Chapter 6: Development and Evaluation of 
Electronic Health Record Data Quality 
Assessment Guideline 
6.1 Introduction 
The previous aims have highlighted the need for systematic methodology for EHR data 
quality assessment within the context of secondary use. Existing reviews of the informatics 
literature have demonstrated that EHR data tend to be of poor and variable quality.(1-3) 
Researchers interested in using EHR data must be given the tools necessary to assess data quality. 
Unfortunately, current approaches to EHR data quality assessment tend to be ad hoc, which limits 
the transparency of data quality findings and the validity and comparability of results from 
research studies that use these data.(4) This is especially disappointing in light of the fact that a 
potential advantage of the secondary use of EHR data is improved generalizability due to the 
increased representativeness of the subjects when compared to more traditional research.(5) 
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A guideline-based approach to EHR data quality assessment has the potential to improve 
the validity, comparability, and transparency of research conducted using EHR data. Guidelines 
also have the potential to decrease the burden placed upon researchers, who must otherwise find 
or develop methods for data quality assessment. Substantial research on clinical guidelines, which 
are also intended to simplify and standardize complex processes, have been shown to improve the 
consistency and quality of care.(6) Ideally, a data quality assessment guideline would do the same 
for the secondary use of EHR data. 
An EHR data quality assessment guideline, however, must be more than just systematic. 
It must also be evidence-based where possible, or at least expert knowledge-based. It must also 
consider the needs and preferences of clinical researchers, who would be the target users. Lastly, 
because EHR data quality is task-dependent, the guideline must be flexible enough to 
accommodate a fitness-for-use approach to assessment; not all data quality measurements and 
measurement methods will be relevant for all research or all data.(7, 8) 
This chapter describes the design and evaluation of 3x3 DQA: Dynamic, evidence-based 
guidelines to enable electronic health record data quality assessment and reporting for 
retrospective research. 
6.2 Methods 
3x3 DQA is the cumulative product of three different studies, each of which identified 
concepts, methods, and priorities that were incorporated into the guidelines. From the beginning, 
the overall goal was for the guidelines to be clear, concrete, knowledge- and evidence-based, and 
actionable. The specifics, however, including the data quality constructs addressed, the 
methodology described, and the manner in which the entire process of EHR data quality 
assessment was approached, were determined by a combination of literature-based, qualitative, 
and data-driven research.  
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6.2.1 Initial Guideline Development 
6.2.1.1 Guideline Format Considerations 
Before beginning the process of designing 3x3 DQA, we knew that it would need to 
contain a great deal of information, which can be overwhelming and confusing if not presented 
properly. Initially, we had intended to develop the guidelines using the SAGE guideline model, 
which can be presented using a simple flowchart approach that includes three types of nodes: 
context, decision, and action.(9) After gaining a deeper understanding of the complexities of EHR 
data quality assessment, however, it became clear that SAGE and other similar models were not 
suitable. The goal of SAGE and other clinical guideline models is to identify a specific end 
action. In EHR data quality assessment, however, there are likely to be multiple end actions (i.e. 
multiple methods to assess the quality of the data). We needed to use a knowledge representation 
model that would allow users to identify multiple relevant constructs of data quality and multiple 
associated methods of data quality assessment.  
Successful representations of complex research processes often present information using 
at least two levels of information. The first level, which is intended to be easily accessible, may 
be a visual or simple textual representation of the framework. More information, in substantial 
detail, is then available if the user wants to proceed with the model or framework. Two examples 
of such an approach are the RE-AIM framework, which can be succinctly summarized by its full 
name (Reach Effectiveness Adoption Implementation Maintenance), and the Precede-Proceed 
model used in Chapter 3 of this dissertation, which is presented as a visual model.(10, 11) Both 
are used to guide the complex planning, implementation, and/or evaluation of public health 
interventions. 
Therefore, we decided that the best approach to the complexities of EHR data quality 
assessment was to use a simple, visual framework that summarizes the process in a conceptually 
clear fashion, coupled with in-depth guidelines describing the assessment methods dictated by the 
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framework. As indicated by the findings of Aim III (Chapter 4), we knew that parts of the 
framework and associated guidelines would not be needed in all use cases, and therefore also 
decided to develop a series of questions that would help users determine the scope of their 
research and identify the relevant sections of the framework and guidelines. 
6.2.1.2 Data Quality Construct Identification 
The constructs of data quality included in the framework were derived from two sources: 
the literature review described in Chapter 2, and the interviews with clinical researchers in 
Chapter 3. The literature review identified five categories of data quality that are described and 
assessed in the informatics literature: complete, correct, concordant, plausible, and current data. It 
was determined, however, that data concordance and plausibility, however, are used as 
methodological proxies for the other categories of data quality, especially correctness. A lack of 
concordance between two variables, for example, indicates that one or both of those variables are 
incorrect. Similarly, when one states that a specific value is implausible, the implication is that it 
is not correct. The connection between concordance, plausibility, and correctness is illustrated in 
a data accuracy assessment comparison hierarchy for healthcare data proposed by Zozus et 
al.{Zozus, Assessing Data Quality for Healthcare Systems Data Used in Clinical Research: A 
Healthcare Systems Research Collaboratory Core White Paper #466} Their hierarchy suggests 
that there are a number of ways to assess the accuracy of healthcare data, ranging from gold 
standard data (rarely available) to known standards and other data values. 
We also decided to set limitations on the scope of the guideline based upon previous 
work on data quality. Wang and Strong defined four broad categories in their hierarchical model: 
intrinsic, contextual, representational, and accessibility data quality.{Wang, 1996 #405} They 
state that the intrinsic constructs are those that capture the quality of data in their own right, 
without knowledge of how the data will be used, while contextual data quality refers to the fact 
that some constructs of data quality are task-dependent. Both are concerned with the quality of 
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the data themselves. Representational data quality and accessibility, however, largely concern the 
systems and formats in which the data are measured, recorded, and stored. EHRs and other health 
information technology systems are extraordinarily complex, which is already the subject of a 
substantial field of research. We decided to limit the scope of our data quality assessment 
guidelines to those aspects of data quality that concern the data themselves, rather than those that 
evaluate systems. 
Table 6.1 EHR data quality constructs, their sources, their categories, and their inclusion status. 
Construct Literature Researchers Proxy Category Included 
Completeness X X 
 
contextual X 
Concordance X X X intrinsic 
 



































Of the seven constructs of data quality identified through interviews with clinical 
researchers, three would be considered aspects of accessibility or representational data quality: 
fragmentation, structuredness, and signal-to-noise. All are concerned with how data are recorded 
and stored, which in turn influences how easy they are to retrieve. Of the four remaining 
constructs, one is concordance, which, as described above, we determined to be a proxy of 
correctness.  Another, granularity, though clearly important to researchers, is very rarely 
addressed in the informatics literature or literature on data quality more broadly. We did not feel 
that there was sufficient information available to make methodological recommendations 
regarding the assessment and reporting of granularity. The remaining two constructs, correctness 
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and completeness, overlap with the three core constructs from the literature review. Table 1 
summarizes the sources and considerations for each of the nine total constructs. 
6.2.1.3 Framework Development 
The primary goal of the framework was to give users a conceptual overview of what data 
quality means, how applies to the secondary use of EHR data, and how data quality assessment 
can be approached from a practical standpoint. Aim III (Chapter 4) demonstrated that EHR data 
completeness can be operationalized in different meaningful ways depending upon what data will 
be needed and how they will be used. Therefore, we determined that the framework should 
extend this concept of multiple operationalizations of the most important data quality constructs, 
which were identified in Aims I (Chapter 2) and II (Chapter 3), and link these operationalizations 
to different possible data “needs” that would in turn be dictated by the user. 
6.2.1.4 Recommendation Development 
The detailed methodological recommendations were dictated by the different 
operationalizations from the framework. Therefore, each data quality construct, having multiple 
operationalizations, would also have multiple recommendations. A primary goal of 3x3 DQA is 
transparency of EHR data quality findings, so the recommendations had to include not only 
methodological approaches, but suggestions for reporting as well. Ideal recommendations are 
knowledge- and evidence-based, so the methodological approaches were pulled from literature on 
EHR data quality assessment and data quality more broadly. Many of these sources were initially 
identified in Aim I (Chapter 2). 
6.2.1.5 Scope Identification Questions 
Once the 3x3 DQA framework had been developed, all combinations of the 
operationalizations were calculated. Next, various assumptions and logical rules were applied, 
and a subset of realistically possible combinations was identified. A series of yes or no questions 
was then developed to help users identify which data quality constructs and operationalizations 
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were relevant for their intended research. The possible combinations of answers to these 
questions corresponded to the subset of operationalizations deemed realistic. 
6.2.2 Evaluation 
Following the initial draft of 3x3 DQA, an expert-based evaluation was developed to 
guide further iterative development of the document. Other evaluation approaches, including 
scenario-based testing and pilot testing with actual users, were determined to be more appropriate 
later in the development process. The evaluation instrument was based largely upon the literature 
on psychometric instrument development and testing. Unfortunately, although this kind of expert-
based testing is often used, it is rarely reported in detail.(12) 
An expert-based evaluation was conducted instead of a user-based evaluation for multiple 
reasons. First, an expert-based evaluation seemed more appropriate at this stage in the 
development of 3x3 DQA. User-based evaluations are more complex and require greater time and 
resources, and it was therefore determined that a lighter-weight expert evaluation and subsequent 
round of iterative design should be performed prior to user-based evaluation. Second, the primary 
goal of this evaluation was to assess the validity, clarity, and comprehensiveness of 3x3 DQA, 
which is especially well-suited to experts. Users, in contrast, are better-suited to evaluating 
features like usefulness and ease-of-use. 
Finally, this was the first opportunity to incorporate expert knowledge and opinions into 
the development of 3x3 DQA. Up to this point, 3x3 DQA had been the product of a literature 
review (Chapter 2), a data-driven exploration of EHR data quality (Chapters 4 and 5), and 
feedback from target users (Chapter 3). Input from actual experts on EHR data quality within the 
context of secondary use, however, had not been elicited in any direct way. This initial 
evaluation, therefore, served not only as a way to determine the overall quality and value of 3x3 
DQA, but also as a way to incorporate expert knowledge and feedback into the further 
development of the framework and guideline. 
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6.2.2.1 Evaluation Design 
The evaluation instrument was designed so as to mirror the levels of the guideline: 
framework and constructs, operationalizations, recommendations, and the scope identification 
questions. The content experts were asked to consider the clarity, validity, comprehensiveness, 
feasibility, and usefulness of the different sections. Each question had a forced binary response 
option, both to make the questionnaire quicker to fill out and to make the results easier to 
analyze.(13)  
At the highest level is the framework, which includes the three constructs of EHR data 
quality. Respondents were asked to assess the clarity and comprehensiveness of the overall 
framework, as well as the clarity and validity of each of the constructs. Next are the nine 
operationalizations of the data quality constructs, wherein each construct is projected onto the 
three data dimensions. The evaluation includes questions about the clarity and validity of each 
operationalization, as well as the comprehensiveness of the operationalizations in capturing each 
construct. Each operationalization is then detailed in actionable terms in the recommendations for 
measurement and reporting. Respondents were asked to assess the clarity and feasibility of each 
of the recommendations. Finally, two general questions were included for the scope identification 
questions, asking the content experts to evaluate the questions in terms of clarity and usefulness. 
Each questionnaire item or set of items also included a space for optional free-form response. The 
complete evaluation instrument is included in Appendix C. 
6.2.2.2 Expert Identification and Recruitment 
Content experts in the area of EHR data quality assessment were identified in one of two 
ways. Either they were collaborators on the PCORI Methods project entitled Building PCOR 
Value and Integrity with Data Quality and Transparency Standards, led by Michael Kahn of the 
University of Colorado Denver, or they were required to have published at least two peer-
reviewed articles on EHR data quality assessment. Ten content experts were identified based 
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upon these criteria, and invited by email to participate in the evaluation of 3x3 DQA. No 
compensation was offered. 
6.3 Results 
6.3.1 Initial Guideline Document 
Version 1.0 of 3x3 DQA can be viewed in its entirety in Appendix D. The guideline 
document is 25 pages long, and includes an introduction, a user guide, scope identification 
questions, the 3x3 DQA framework, data quality assessment and reporting recommendations, and 
relevant references.  
6.3.1.1 The 3x3 DQA Framework 
The 3x3 DQA framework, which is at the heart of the guideline document, is shown in 
Figure 2. Based on the data quality categories identified in Aims I (Chapter 2) and II (Chapter 3), 
three core constructs of data quality were selected as being essential for the secondary use of 
EHR data. To be fit for use, EHR data must be complete, correct, and current. These constructs 
are defined in Table 2: 
Table 6.2 Core data quality constructs and definitions from 3x3 DQA. 
Construct Definition 
Complete Data are sufficient in quantity for the task at hand. 
Correct Data are free from error. 
Current Data were recorded at the desired relative or absolute time(s). 
 
These three constructs are then operationalized across the three potential dimensions of 
EHR data: patients, variables, and time. These data dimensions correspond to the standard 
dimensions of data flat files and cubes. Patients are equivalent to rows, variables to fields, and 
time to the longitudinal dimension that is present in some datasets. These data dimensions were 
originally identified in Aim III (Chapter 4), and were used as the basis of three of the definitions 
of completeness described therein. It is theoretically possible that a fourth data dimension could 
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be added to represent the possibility of including data from multiple institutions. The inclusions 
of multiple data sources would dictate the operationalization of the three data quality constructs 
across institutions. Comparisons of variables between institutions, for example, could indicate 
problems with correctness. 3x3 DQA could easily accommodate this fourth data dimension, but 
because the majority of the foundational research in Aim II (Chapter 3) and Aim III (Chapter 4) 
were conducted at a single institution, it was determined that it was more appropriate to limit the 
scope of the framework and guideline to a single institution as well. 
 
Figure 6.1 3x3 DQA framework. Data quality constructs are at the top, data dimensions along the side, and cells 
contain corresponding operationalizations. 
 
Each cell corresponds to the operationalization of one of the three data quality constructs 
across one of the three data dimensions. Correctness, which is especially difficult to measure 
without a reference standard, is operationalized through concordance (agreement between values) 
and plausibility, which are often viewed as independent categories of data quality in the 
informatics literature, but are generally proxies for correctness.(4) 
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6.3.1.2 Recommendations for Assessment and Reporting 
 
Figure 6.2 One of two recommendations for measuring and reporting if a dataset is correct across the patient 
dimension, which is operationalized as “Is the distribution of values across patients plausible?” 
 
Each operationalization within the framework has an associated recommendation for 
assessment and reporting, except for the assessment of correctness across patients (cell 1B), 
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which has two recommendations. Notably, the recommendations do not address implementation, 
which is highly dependent upon the data of interest, and often require the user to call upon 
relevant domain knowledge. The recommendations also do not include “cut-offs,” or points at 
which a dataset would be deemed to be of sufficient quality. Such a determination must be made 
by the user depending upon their understand of the data being used, the clinical phenomena being 
examined, and the methods of analysis utilized. 
Each recommendation has four sections: measure, report, example, and references (where 
available). “Measure” describes how to actually assess the data quality construct as described in 
the relevant operationalization, “Report” indicates what needs to be included when describing 
data quality findings. This includes not only the numerical results of the measurement process, 
but also any rules that were put in place for purposes of assessment. “Example” presents a simple 
demonstration of how the measure would be implemented, and what would be reported, 
sometimes with relevant visualizations. Finally, “references” supplies source and example 
publications for the specific measures described in the recommendation, allowing users to read 
further if they so choose. See Figure 3 for an example of a recommendation page from the 
guideline document. 
6.3.1.3 Scope Identification Questions 
There exist 512 combinations of the nine data quality assessment operationalizations. By 
applying a number of logical constraints to these combinations (e.g. all use cases will require 
correct and complete data, but not necessarily current data), we identified 26 realistically possible 
combinations. The possible combinations depend upon which data dimensions (patients, 
variables, time) were included in the target dataset, and which aspects of currency were important 
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Table 6.3 Possible combinations of 3x3 DQA operationalizations. 
Data dimensions to assess  Operationalizations of currency 
Multiple patients, variables, 
and time points.  
Check timeframe, relative order, and frequency of points. 
Check timeframe and relative order, but not frequency of points. 
Check timeframe and frequency of points, but not relative order. 
Check timeframe, but not frequency of points or the relative order. 
Check frequency of points and relative order, but not timeframe. 
Check relative order, but not timeframe or frequency of points. 
Check frequency of points, but not timeframe or relative order. 
Don't check timeframe, relative order, or frequency of points. 
Multiple patients and 
variables, but only one time 
point. 
Check timeframe and relative order, but not frequency of points. 
Check timeframe, but not relative order or frequency of points. 
Check relative order, but not timeframe or frequency of points. 
Don't check timeframe, relative order, or frequency of points. 
Multiple patients and time 
points, but only one 
variable. 
Check timeframe and frequency of points, but not relative order. 
Check timeframe, but not relative order or frequency of points. 
Check frequency of points, but not timeframe or relative order. 
Don't check timeframe, relative order or frequency of points. 
Multiple variables and time 
points, but only one patient. 
Check relative order and frequency of points, but not timeframe. 
Check relative order, but not timeframe or frequency of points. 
Check frequency of points, but not timeframe or relative order. 
Don't check timeframe, relative order, or frequency of points. 
Multiple patients, but only 
one variable and one time 
point.  
Check timeframe, but not relative order, or frequency of points. 
Don't check timeframe, relative order, or frequency of points. 
Multiple variables, but only 
one patient and one time 
point. 
Don't check timeframe, relative order, or frequency of points. 
Check relative order, but not timeframe or frequency of points. 
Multiple time points, but 
only one patient and one 
variable. 
Check frequency of points, but not timeframe or relative order. 
Don't check timeframe, relative order, or frequency of points. 
 
The scope identification questions are organized in three phases. The first includes three 
questions that ask users to consider whether they have more than one variable, patient, and time 
point in their study, in order to determine which data dimensions (the framework rows) are 
relevant to the intended study (see Figure 4). Phase two includes a total of eight questions, though 
users will only be asked to respond to one of them. These questions check to make sure the user 
has identified the correct data dimensions. The third and final phase includes three questions, and 
again the user will determine which one to answer based upon their responses to the phase one 
questions. These questions help the user determine which operationalizations of currency are 
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relevant to the intended study. Upon completing the scope identification questions, the user 
should know which operationalizations and, by extension, which recommendations are necessary 
for the intended study. 
 
Figure 6.3 The phase one scope identification questions. These questions help the user determine which data 
dimensions are relevant to their study, which in turn dictates which data quality operationalizations and 
recommendations are necessary. 
 
6.3.2 Quantitative Evaluation Results 
Of the ten content experts who were asked to participate in the evaluation, nine expressed 
interest in the project, and five completed and returned the evaluations before May 28, 2014. The 
quantitative and qualitative results for the five responses are summarized below. Only two 
participants responded to the questions regarding the questions to identify scope, so those 
questions and their responses were not included in the analysis. 
Of the five participants who completed the evaluation, two thought the framework was 
valid, and two thought it was clear. The three constructs of data quality also received low marks, 
which are summarized in Figure 5. The responses to the operationalizations, shown in Figure 6, 
were more mixed. The recommendations received the most positive responses overall, as shown 
in Figure 7. 
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Figure 6.4 Number of content experts who thought the three data quality constructs were clear and valid. 
 
Figure 6.5 Number of content experts who thought the nine operationalizations were clear and valid, as well as 
the number who thought that the three operationalizations for each construct were comprehensive. 
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6.3.3 Qualitative Evaluation Results 
The overall response to 3x3 DQA was positive. One content expert called the guideline 
“a coherent and thoughtful piece that should support research activities in an important way.” 
Another said, “This is really great and very nicely presented.” All five respondents, however, had 
significant critiques and suggestions.  
6.3.3.1 Framework Responses 
Based on their comments, none of the respondents had problems with the clarity of the 
framework structure, which features the quality constructs projected across the data dimensions. 
Four out of the five, however, had issues with at least some of the wording used in the 
operationalizations, which are featured in the framework cells. One respondent also felt that there 
needed to be more clarity regarding when in the research process the framework would be 
applied. In terms of comprehensiveness, three respondents had suggestions for features of data 
quality they felt should be included: ensuring proper mapping and matching between different 
data elements (patients, variables, etc.), consistency of representation, inclusion of the right 
patients (i.e. cohort selection), and methods for identifying and removing duplicate records. 
Construct Responses 
Of the three constructs, the definition of complete data had the highest overall ratings. 
One evaluator, however, felt that the inclusion of the phrase “task at hand” in the definition made 
the construct both unclear and potentially invalid. Another felt that the construct was both unclear 
and invalid because it was likely that a research scenario would be designed around a dataset, not 
that the dataset would be evaluated for a given research scenario: “Typically, a researcher will 
evaluate data quality/availability and develop a research design appropriate for the data. One 
question is whether the data are sufficient/appropriate given the research design. Without 
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Responses to the complete data definition were mixed, with three complaints being about 
the phrase “free from error.” One content expert thought the definition was valid, but unclear 
because the meaning of “error” was unspecified, while the other two felt the phrase made the 
definition both unclear and invalid. All three emphasized that the source of error must be 
considered (e.g. incorrectly measure, incorrectly recorded, incorrectly retrieved, etc.). In contrast, 
another respondent stated, “This is simple—‘free from error’—which is good.” 
The definition of current data had the lowest rating for clarity of the three constructs. 
Three of the respondents requested clarification regarding whether the time of interest was when 
the data point was measured or when it was recorded, suggesting that the latter is not informative, 
and also that it is not always available. One respondent wrote, “…the time of recording [a 
vaccination] may not be meaningful and is often not transferred as metadata with [the] dataset, 
but the date I put down as the receipt date is the time that is important for data users.” A different 
content expert also pointed out that the term “current” usually means “up to date,” and that 
“timely” was perhaps a better word for this construct. 
6.3.3.2 Operationalization Responses 
Two of the respondents had significant concerns about the clarity and validity of the 
operationalizations of complete data. One disliked the use of the term “sufficiency,” and seemed 
to want to move towards a less task-dependent definition of complete data and have some type of 
denominator for patient counts. Another felt the concept of time as it was used to characterize a 
denominator was unclear and unhelpful. There was also a concern that the three 
operationalizations are all ways of measuring the same thing, and do not give different 
information: “To me, these are all the same question. I want to know whether my cohort has the 
right data available for a study, during the study period. It is one question to me, not three.”  
The operationalizations of complete data were the most popular, though two respondents 
felt that the use of the word “concordance” was unclear. One content expert also disliked that all 
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three operationalizations relied upon external knowledge, and also wished that the data quality 
assessment considered the data lifecycle (i.e. measurement to recording to extraction). Another 
respondent, however, highlighted these as being the strongest part of the guideline overall. 
As with the overall construct of current data, the individual operationalizations of current 
data had the lowest overall ratings of clarity. Three respondents disliked the phrase “desired 
order,” and were not sure what it meant. Two disliked the emphasis on user decision-making (i.e. 
“timeframe of interest,” “desired order,” and “desired regularity”). One of the two suggested that 
if we wanted to emphasize task-dependence, it might be better to use consistent phrasing across 
all operationalizes (e.g. “sufficient,” as in the complete data operationalizations, instead of 
“desired”). One of the content experts suggested that we include a measurement of the time 
between when an event occurred and when it was recorded. 
6.3.3.3 Recommendation Responses 
One of the content experts did not write comments for the individual recommendations, 
but instead stated, “These recommendations…are where this comes to life. I’d be hesitant to 
make it too formal…but there are key recommendations that everyone should do before using a 
data source.” 
Two of the content experts had significant concerns regarding the clarity and feasibility 
of the recommendations for measuring and reporting on complete data. One would have preferred 
that the recommendations be clearer regarding how judgments would be made regarding if a 
dataset met the necessary threshold for quality. “[The recommendations] are about availability. 
The recommendations say nothing about the judgment that is required to turn availability into 
sufficiency…” Another respondent said that the term “variable” had to be clearly defined in order 
to be applied, and also said that these measures might be difficult to execute for large datasets.  
For the most part, the content experts were satisfied with the feasibility and clarity of the 
recommendations for measuring and reporting data correctness. There were a few small 
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suggestions, including being more explicit about how many variables had to be assessed and 
defining concordance. The majority of the comments came from one respondent, who had 
significant suggestions for all three recommendations. For the first approach for assessing 
correctness across patients, this content expert suggested distinguishing between plausible values 
within an individual record versus across all patient records, and for the second approach pointed 
out that the identification and use of an external benchmark is not always feasible. This 
respondent was also concerned about the burden of having users come up with their own rules to 
assess concordance between variables and the plausibility of sequences of data. Lastly, this 
respondent also pointed out that it could also be useful to assess trends of data at the population 
level, not just the patient level. 
One major concern regarding the feasibility of the recommendations for current data was 
that the assessments relied upon the availability of certain log data or metadata (e.g. time when 
the data were recorded), which may not always be included in a dataset. Two of the content 
experts disliked the phrase “within range” in the recommendation for assessing currency across 
patients, and felt it was misleading. Three of the respondents disliked the use of formal 
calculations described for assessing currency across time, or at least felt it was out of line with the 
rest of the recommendations. 
6.3.3.4 Questions to Identify Scope Responses 
Only two of the content experts included comments on the scope questions. One thought 
the questions were a good start, but that their clarity would be improved by emphasizing the 
importance of context (i.e. the intended research). Another felt that many of the questions were 
unhelpful, since most research would have the same requirements, and suggested that some 
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Table 6.4 Triangulation of experts' quantitative and qualitative feedback. 
Framework Constructs Operationalizations Recommend. 
Sample Expert Statements 














 yes 0 0 4 3 1 8 8 Typically, a researcher will evaluate data quality/availability and develop a research design 
appropriate for the data. 
Recording a diagnosis code for “diabetes” in an EHR during a visit in which the clinician orders a 
test for diabetes is not necessarily an error, it might be a local policy that all diabetes tests ordered 
get coded with that diagnosis. 
I want to know whether my cohort has the right data available for a study, during the study 
period. It is one question for me, not three. 
These recommendations…are where this comes to life. 
  0 0 1 6 0 5 6 I think missing from the framework is actually the frame—when in the research process are we 
supposed to use this? It seems to be aimed at the analysis of a data set—after the data-collection 
process has been specified. 
[T]he concept missing for me is my data-quality workflow, as a quality assessor or researcher. 
You saw my earlier comment before, the “pathway” of data from physical event to recording in 
the dataset. These three operationalizations don’t cover all of them, so I presume you are making 
a choice based on some sort of tradeoff, having to do with ease of checking. 
yes  3 2 6 6 0 7 9 Again it is contextual—fitness for purpose definition. But overall the logic of self-assessment and 
self-determination of what “sufficient” is makes sense. 
Progression on data over time reflects clinical course and will vary depending on a number of 
diagnostic, management and prognostic factors. So need constraints in framing the research 
question(s). 
I think the realist approach should be emphasized, i.e. the importance of context. 
The issue of “actors” is another important scope question as EHR-based research can be used for 
research about the care provider and interventions as well as impact on patients. 
yes  0 2 9 9 3 4 3 I don’t see anything to address the quality issue of, “Are the right patients included in the data?” 
Perhaps this is more of a research question…but it seems to cross into the data quality boundary 
when someone attempts to use the data for something that’s not fit for purpose. 
[I]t feels as if [completeness] depends on the ‘task at hand.’ If the goal is to estimate an effect, 
then completeness requires that the estimate can be generated without bias due to confounding. 
[Using an] external reference is a good idea, but practically is quite difficult, both in terms of 
logistics and methodologically ensuring that the external reference should be comparable to the 
source population.  
 yes 2 3 7 8 3 8 7 Each construct seems like it should be followed by the term “for the task at hand.” 
[The completeness across patients recommendation] may be difficult for larger datasets, 
composite variables, and deciding when to do this…where does this get represented? 
[For the current across patients recommendation,] this is clear—I’m not sure how feasible it is. 
[For the current across time recommendation,] without metadata for recording data I’m not sure 
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6.3.4 Data Triangulation 
As a complement to the separate qualitative and quantitative results for each section of 
3x3 DQA, we also looked at the responses for each expert. Table 4 shows a summary of each 
expert’s quantitative scores and a selection of their key qualitative comments.  The purpose of 
this table is to demonstrate how each expert’s feedback hangs together throughout the evaluation. 
6.4 Discussion 
While the overall response to 3x3 DQA was positive, the quantitative and qualitative 
results both indicated that there is significant work to be done to improve validity, clarity, 
comprehensiveness, and feasibility. The content experts, for example, largely disregarded the 
scope identification questions. This result suggests that the scope identification questions either 
need to be significantly improved, or not included at all. The recommendations, in contrast, had 
relatively high levels of approval, and the problems mentioned by the content experts should be 
relatively easy to fix. 
Each expert had at least one overarching concern or guiding principle in their evaluation 
(see Table 4). The first expert felt strongly that the context in which the data was originally 
collected and maintained was vitally important to understand the meaning of the data, and also 
disliked the more abstract parts of the guideline, particularly the construct definitions and, to a 
lesser extent, the operationalizations. This expert, however, liked the concrete suggestions 
contained within the recommendations. The second expert believed that in order to understand 
data quality it was necessary to understand the underlying processes and lifecycle of the data, and 
felt that a weakness of the entire guideline was that not explicitly stated when in the data lifecycle 
3x3 DQA was intended to be used. The third expert comes from a strong background in 
ontological science, and therefore felt that the guideline needed to be more ontologically 
coherent. This expert also felt that the importance of context and the concept of fitness-for-use 
needed to feature more centrally in the guideline. The fourth expert also emphasized the 
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importance of context in the meaning of the three core constructs of the guideline, and believed 
that the identifying a research question was necessary to understand how any of the constructs 
would really be operationalized and implemented. The fourth reviewer, along with the fifth 
reviewer, was also very concerned about the feasibility of some of the recommendations, and 
believed that some of them would be difficult to carry out in practice, particularly with large 
datasets or unique patient populations. 
There were a few major lessons that can be applied to the entirety of 3x3 DQA. One is 
the importance of phrasing and terminology. The three data quality construct definitions (and the 
word “current”) all received major criticism. The operationalizations also received low ratings on 
clarity, especially for current data. The way in which data quality is defined and operationalized 
is clearly both important and complex. Part of this complexity stems from the lack of consistency 
in thought on how best to describe and represent data quality. The disagreement over the 
definition of correct data is a good example: three respondents disliked the term “free from error,” 
while another singled it out as the best definition. Going forward, there is significantly more work 
to be done on the definitions and operationalizations of the constructs. 
Another major lesson is the major goals and guiding principles of the development of 3x3 
DQA need to be more clearly laid out in the actual document. Specifically, we wanted the 
guideline to embrace the task-dependent nature of EHR data quality and data quality assessment, 
as well as the central role of the target users (clinical researchers) in determining how to apply the 
recommendations and whether or not data were of good enough quality for their purposes. The 
comments, however, suggested that these two principles were sometimes unclear, with one 
content expert explicitly disliking the use of terms like “sufficient” or “desired.” Therefore, 3x3 
DQA may need to have a more clear “mission statement” that highlights the guiding principles 
and explains how they were derived. 
One of the limitations of this evaluation was the choice to use a forced binary choice for 
the survey items, rather than a Likert scale. Forced binary items are ideal for when one wants to 
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determine if an individual completely agrees with a survey item. Therefore, from an iterative 
design perspective, forced binary items were useful. If one of the experts was at all unsatisfied 
with some aspect of 3x3 DQA, we wanted to know this, because it meant that further work was 
required. From an analysis standpoint, however, a forced binary item results in limited 
information. With a Likert scale a tester can convey a range of satisfaction or dissatisfaction, 
which would have allowed for more in-depth analysis of the responses to 3x3 DQA. As it is, there 
is not sufficient data to determine if some aspect of the guideline is “close to comprehensive” or 
“nearly valid.” Rather, if a respondent interpreted the binary items strictly to mean 
“comprehensive” versus “not comprehensive,” we can only determine if they felt some work was 
still needed, not how much work was still needed.  
 A final point is that there is always a trade-off between clarity and complexity. One of the 
goals of 3x3 DQA was to impose a coherent conceptual framework onto the lengthy and difficult 
process of EHR data quality assessment. In improving the clarity and usability, however, there 
was a loss of scope and complexity. There are only three data quality constructs included in the 
guideline, as opposed to the fifteen defined by Wang and Strong or the five identified in the 
literature review and the seven identified in the interviews described in Chapters 2 and 3 of this 
dissertation.  The decision to only assess complete, correct, and current data was made in part 
because these were identified as the core constructs of EHR data quality, but also because 
including all possible constructs could easily become unmanageable.  Likewise, the decision to 
project these three constructs across the three data dimensions was intended to operationalize 
EHR data quality in a logical and actionable fashion, but it is also a design choice. It is important 
to determine if the losses in scope and complexity are outweighed by the gains in coherence and 
clarity, as well as if there are ways to improve the balance. 
136 
 
  Chapter 6: Guideline 
6.4.1 Future Work 
The next step in the iterative development of 3x3 DQA will be another round of design 
and improvement, based upon the feedback of the five content experts.  After that, it is vital that 
the guideline undergo scenario testing and pilot testing. While experts are important in 
establishing the underlying conceptual basis and validity of the guideline, user experiences and 
feedback are necessary for further development. Finally, the actual impact of 3x3 DQA will need 
to be evaluated. Does using 3x3 DQA increase the quality of research conducted using EHR data?  
Does it improve the awareness and knowledge of researchers for appropriately selecting and 
applying pertinent data quality measures? Does it improve the transparency of research and also 
the interpretability of the research results? And most importantly, does it improve the validity of 
research conducted with EHR data? This last question is especially hard to answer, since it 
requires the establishment of a difficult baseline: what is the validity of research conducted with 
EHR data without data quality assessment, or with ad hoc approaches to EHR data quality 
assessment? 
6.5 Conclusions 
This chapter describes the first two phases in the iterative design of a guideline for EHR 
data quality assessment: the initial design and an expert evaluation. 3x3 DQA is a standalone 
document targeted at clinical researchers engaged in the secondary use of EHR data. It is meant 
to embrace a fitness-for-use approach to data quality that is flexible enough to accommodate 
different study designs and data requirements. Rather than relying upon the availability of a 
reference standard, the 3x3 DQA guides users in utilizing external sources of medical information 
and knowledge to evaluate data quality. The guideline results from qualitative, data-driven, and 
literature-based investigation to understand and assess EHR data quality issues. 
Based on an evaluation of the validity, clarity, comprehensiveness, and feasibility of 3x3 
DQA by EHR data quality content experts, the guideline appears to be a promising start, though it 
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requires significant continual development. Specifically, the constructs and operationalizations of 
EHR data quality need to be improved, and primary goals and principles of the guideline to be 
explicitly stated and explained to intended users. Automated execution of the guideline should 
also be explored to reduce cognitive overhead for potential users to interpret the complex 
guideline logic.  Further iterations of 3x3 DQA will require extensive testing and evaluation to 
demonstrate real world usefulness and impact. 
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Chapter 7: Conclusions and Future Work 
7.1 Introduction 
This dissertation investigates the problems and priorities of electronic health record 
(EHR) data quality and data quality assessment within the context of secondary use. The first 
study (Chapter 2) was a literature review that established the need for a systematic approach to 
EHR data quality assessment. The second (Chapter 3) was a qualitative study exploring clinical 
researchers’ perceptions of EHR data and attitudes towards their reuse for research, and 
demonstrated the prominent need for EHR data quality assessment methods, as well as the desire 
for clinician involvement in the validation and reuse process. The third study (Chapter 4) featured 
a data-driven approach to EHR data completeness, which demonstrated that EHR data quality is a 
task-dependent phenomenon. The fourth study (Chapter 5), inspired by the third, explored the 
connection between patient health and EHR data completeness, and established that there is a risk 
of sampling bias in the reuse of EHR data when imposing data sufficiency requirements. The last 
study (Chapter 6) describes the development and expert-based evaluation of 3x3 DQA, a 
dynamic, evidence-based guideline to enable EHR data quality assessment and reporting for 
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retrospective research that incorporates the major lessons and principles demonstrated by the 
previous chapters of this dissertation. 
7.2 Contributions 
This dissertation makes two primary contributions to the improvement of the secondary 
use of EHR data. Aims I, II, III, and IV led to the discovery and development of guiding 
principles and best practices in the reuse of EHR data and data quality assessment. These best 
practices, in turn, were used to guide the design of 3x3 DQA, the other primary contribution of 
this dissertation. 
7.2.1 Best Practices for EHR Data Quality Assessment 
From Aim I, the literature review, we learned that current approaches to EHR data quality 
assessment are ad hoc and overly reliant upon arbitrarily chosen reference standards, which are 
not always available. Aim I also resulted in five categories of data quality and seven approaches 
to data quality assessment that may be applied to EHR data quality reuse or, in the future, other 
sources electronic health data (e.g. registry data or social media data). 
In Aim II, the interviews, we learned that clinical researchers are aware of EHR data 
quality problems, but intend to engage in the secondary use of EHR data despite these problems, 
indicating that there is an immediate need for data quality assessment methodology is. The 
interviews also indicated that to be accepted by clinical researchers, an EHR data quality 
assessment tool should engage the user in the evaluation and decision making process. The 
interviews also led to the identification of seven possible categories of EHR data quality. 
Aim III, which was the data-driven exploration of completeness, proved that EHR data 
quality is a task-dependent phenomenon, which means that any approach to EHR data quality 
assessment should abide by the principle of fitness-for-use. This aim also demonstrated that EHR 
data quality can be operationalized across the data dimensions of variables, patients, and time. 
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In the course of Aim IV, which looked at the relationship between patient record 
completeness and patient health status, we proved that by naively selecting patient records with 
sufficient data for a given study, researchers may inadvertently bias their cohort towards sicker 
patients, thereby limiting the external generalizability of their research.  
7.2.2 EHR Data Quality Assessment Guideline 
The best practices described above were used as guiding principles in the development of 
3x3 DQA, which is the primary contribution of this dissertation. 3x3 DQA is a dynamic, 
evidence-based guideline meant to enable EHR data quality assessment and reporting for 
retrospective research. Though not yet ready for dissemination (further iterative development, 
evaluation, and testing are required), the guideline is a promising approach for improving the 
efficiency, validity, and transparency of research relying on the secondary use of EHR data. 
7.3 Future Work 
7.3.1 Designing and Evaluating 3x3 DQA 
 Although feedback from the content experts who participated in the initial evaluation of 
3x3 DQA was largely positive, it is clear that further improvements and testing are needed. The 
design process behind the guideline is iterative. Following redesigns based upon the evaluation 
described in Chapter 6, the guideline will need to undergo further testing, likely followed by 
further redesign.  
Future testing efforts will be needed to establish the validity and reliability of 3x3 DQA, 
possibly using techniques for psychometric instrument development.(1) Ideally, evaluation will 
also include scenario-based testing with representative users, and eventually pilot testing with real 
data and real research. It is important that the actual real world impact of the guideline be 
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It is also hoped that further iterations of 3x3 DQA will include a partially automated data 
quality assessment “toolkit,” which will eliminate some of the complex implementation processes 
that currently interfere with the guideline’s comprehensibility and use. Some degree of user 
guidance and training will always be required—by necessity and by design—but some of the 
burden could and should be decreased, improving efficiency and consistency. 
7.3.2 Putting 3x3 DQA into Practice 
Following another round of iterative design based upon the expert evaluation described in 
Chapter 6, the next phase of testing will be to use 3x3 DQA with actual EHR data. The goal of 
this work will be to determine the usability and usefulness of 3x3 DQA when used by target users 
in real-world settings with the intended sources of data. This implementation should reveal the 
usefulness and usability of the guideline, as well as its effectiveness in revealing data quality 
problems and the potential of the guideline to alleviate the burden of ad hoc approaches to data 
quality assessment. 
A number of opportunities to implement 3x3 DQA in applicable research situations exist. 
One such opportunity exists at the University of Colorado, Denver, where Dr. Lisa Schilling has 
proposed piloting of 3x3 DQA on an EHR-derived dataset that has been compiled for a planned 
study.  Another opportunity exists at the Oregon Health and Science University, where I will be 
working beginning in the fall of 2014. 3x3 DQA will likely serve as the basis upon which much 
of my future research efforts will be based, including an exploration of the impact of data quality 
upon the findings of research conducted using EHR-derived data. 
Certain features of 3x3 DQA will also be incorporated into other models of EHR data 
quality assessment. Dr. Meredith Zozus at Duke’s Translational Medicine Institute has adapted 
the operationalizations of completeness from 3x3 DQA as part of her work as a member of the 
NIH Research Collaboratory on pragmatic clinical trials and the use of healthcare data.{Zozus, 
2014 #466} Certain features of 3x3 DQA are also being incorporated into the work of the PCORI 
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methods group led by Dr. Michael Kahn at University of Colorado, Denver. The parts of 3x3 
DQA that focus on EHR data completeness have been especially well-received, and will probably 
be included within the PCORI unified model. In both cases, the elements derived from 3x3 DQA 
will eventually be used with EHR-derived datasets, providing an opportunity where features of 
the guideline can be piloted in real-world situations. Such work will be ideal for evaluating 
patient-centered datasets like those being compiled as part of the PCORnet project. 
7.3.3 Exploring the Data Lifecycle  
All of the work described in this dissertation either uses or acts upon data after the point 
of extraction from the Columbia University Medical Center’s clinical data warehouse. There 
exists significant interest, however, in the assessment and improvement of EHR data quality 
earlier in the data lifecycle. Assessing data quality after extraction has the potential to improve 
the validity of research conducted using the data. Assessing the data within the clinical system 
can improve patient care, clinical workflow, and quality of care. 
The EHR data lifecycle is constantly and iteratively evolving. Each time a patient has 
contact with the healthcare system their record may receive additional notes, medication actions, 
laboratory results, etc. The patient record is an incredibly complex, living document, and the 
processes by which data are entered already place extensive time requirements upon clinicians. 
Therefore, efforts to assess or improve data quality prior to extraction must be developed and 
implemented in such a way as to prevent additional burden. There may be specific points in the 
EHR data lifecycle where data quality is already a focus, though perhaps not overtly. Medication 
reconciliation is an example where this already occurs to some extent.(2, 3) Although the purpose 
of medication reconciliation is to improve patient care by preventing medication errors, the 
process also leads to improved data quality, and can be used to assess data quality. Finding other 
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7.3.4 Patient Engagement 
Another possible approach to EHR data quality assessment and improvement is through 
increasing patient engagement. The growing presence of patient communities like 
PatientsLikeMe and individuals like Dave deBronkart (e-Patient Dave) indicate that there are 
significant sub-populations of patients who are eager to be participants in their own healthcare 
and the clinical research process. Improving patient access to and awareness of their electronic 
clinical data may be one untapped opportunity to encourage patients to assess and improve EHR 
data quality. This is most commonly done through patient portals or personal health record (PHR) 
systems,(4) which can be accessed by patients at home. More recently, however, there have been 
efforts to engage patients in the inpatient setting,(5) where they may be more likely to review 
their own data. 
It may also be possible to triangulate data from the EHR and other health information 
technology (e.g. pharmacy data), as well as other entirely disparate sources of health data (e.g. 
social media) and demographic data (e.g. census data) in order to improve overall health-related 
data quality.(6) 
7.4 Conclusions 
This dissertation and the work described herein represent a promising step towards the 
development of best practices for and systematic approaches to the assessment of EHR data 
quality within the context of secondary use. This is an incredibly complex area, and there is still a 
great deal of work to be done. The promise of EHR data reuse, however, as well as the eagerness 
of researchers to use the data, elucidates the need to make this work an immediate and ongoing 
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 Information Sheet and Consent Form for Researcher Interviews 
Research Purpose 
The purpose of this interview is to explore researcher perceptions of the quality and suitability of EHR 
data for clinical research, as well as how these attitudes translate to actual research intentions and 
practices. To accomplish this goal, the aims of this study are to: 1) develop a theoretical understanding of 
researcher beliefs and concerns regarding the quality of EHR data and their reuse for clinical research 
and 2) learn how researchers define data quality and its dimensions.  
Information on Research 
We invite you to participate in an approximately 60 minute interview during which we will ask you to share 
your opinions about Electronic Health Record data and their quality and suitability for reuse in clinical 
research. With your permission, we will audio record and transcribe the interview to summarize your 
perceptions. You may be contacted with follow-up questions in the future. 
Potential Risks 
A potential risk is loss of confidentiality regarding your participation in the interview. However, the audio 
recording of the interview will be stripped of identifying information and stored in a locked office. The 
transcription of the interview will be also be de-identified, and will be stored in a password-protected 
computer in a secure area. Your opinions will not be linked with your name in reports of research findings.   
Potential Benefits 
There are no direct benefits to interview participants. We may share the study results with you at a later 
time, as well as invite you to our informatics workshop on “secondary use of clinical data for research.” 
Alternative Procedures 
The alternative is to not to participate in the interview. 
Compensation 
You will receive $25 per hour in compensation for your participation in the interview. 
Additional Costs 
There are no costs to you for participating in the interview. 
Additional Information 
If you have any questions or concerns about the study, you may contact Nicole Weiskopf at 347-216-
0520 or via email at nicole.weiskopf@dbmi.columbia.edu.  If you have any questions about your rights as 
a research subject you may contact the Columbia University Medical Center Institutional Review Board at 
212-305-5883. 
Confidentiality 
Although every effort will be made to protect the confidentiality of your interview data, absolute 
confidentiality cannot be guaranteed. By participating in the interview you grant permission for your 
interview data to be made available to: 
- The investigator and study staff who may be evaluating the study; 
- Columbia University; 
- Authorized representatives of the Office of Human Research Protections (“OHRP”); and 
- The Columbia University Institutional Review Board (“IRB”) that independently reviews the study to 
assure adequate protection of research participants, as required by federal regulations. 
The investigator, regulatory authorities, and IRB may keep the research records indefinitely. If the results 
of the study are published or presented at a medical or scientific meeting you will not be identified. 
Voluntary Participation 
Your participation in the interview is voluntary. You may decide not to participate in the interview. If you 
decide to participate, you are free to withdraw from the interview at any time. Your refusal to participate, 
or your early withdrawal, in the interview will not affect any benefits to which you are otherwise entitled 
from Columbia University. 
________________________________  _________________ 
Signature     Date 
________________________________  _________________ 
Signature of Person Obtaining Consent  Date
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Interview Guide 
I. Actual Use of EHR data for research 
a. Why don’t you start by briefly telling me about the type of clinical research you 
do? 
b. Have you ever used EHR data for research purposes?  
i. Yes 
1. Could you tell me how you’ve used EHR data in clinical research? 
E.g. what you were studying, the research design, etc. 
2. Can you think of some specific positives or negatives that arose 
from using EHR data? 
ii. No 
1. Why not? 
 
II. Perceptions of EHR DQ 
a. Defining data quality 
i. What does the term data quality mean to you? 
ii. Specifically in the context of reusing EHR data for clinical research, what 
do you think are the most important aspects of data quality?  
iii. Are there any special considerations related to data quality in this 
situation? 
b. Opinions of EHR DQ 
i. Overall, what are your thoughts on the quality and suitability of EHR data 
for research? 
ii. Do you think EHR data quality differs by type of element? E.g. notes, 
labs, diagnoses, medications, etc. 
 
III. Intent to use EHR data for research 
a. Are there types of research that you would be more likely to conduct using EHR 
data? 
b. Given the opportunity, would you use EHR data to for clinical research? 
i. Do you intend to conduct clinical research using EHR data? 
 
IV. Wrap-up 
a. Is there anything else related to the topic of EHR data quality and clinical 
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Introduction 
Thank you for agreeing to evaluate 3x3 DQA, a data quality assessment guideline.  
Please consider the context of secondary use of electronic health record (EHR) data in 
retrospective research when responding to the evaluation questions.  Your responses 
will be used to guide further development of 3x3 DQA. 
If you have any questions or comments, please contact Nicole Weiskopf at 
ngw2105@columbia.edu.                                                     
What to expect: 
This evaluation is formatted to mirror to the framework and recommendations, which 
have four levels: 
1. The framework 
2. The three data quality constructs: complete, correct, and current 
3. The three operationalizations of each construct, which correspond to the 
nine cells of the framework 
4. The recommendations for each operationalization, which describe how to 
perform and report data quality measurements 
The evaluation ends with two questions regarding the scope identification questions. 
You will be asked to evaluate the clarity, validity, comprehensiveness, feasibility, and 
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Framework (page 11) 
 
☐ Clarity: The framework is easy to interpret and understand. 















☐ Comprehensiveness: The framework captures all the constructs of data quality 
that are relevant to EHR data quality assessment within the context of secondary use. 
If not, what other constructs should be included? 
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Constructs (page 10)  
Definition: “Complete Data are sufficient in quantity for the task at hand.” 
☐ Clarity: The definition of complete data is easy to interpret and understand 
☐ Validity: The definition is representative of data completeness 







Definition: “Correct data are free from error.” 
☐ Clarity: The definition of correct data is easy to interpret and understand 
☐ Validity: The definition is representative of data completeness 







Definition: “Current data were recorded at desired relative or absolute time(s).” 
☐ Clarity: The definition of current data is easy to interpret and understand 
☐ Validity: The definition is representative of data currency 
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Operationalizations of Complete Data (Framework cells, page 11) 
Clarity: Which of the following are easy to interpret and understand? 
☐ “Are there sufficient data points for each patient?” 
☐ “Are there sufficient data points for each variable?” 
☐ “Are there sufficient data points for each time?” 








Validity: Which of the following are representative of the construct of data 
completeness? 
☐ “Are there sufficient data points for each patient?” 
☐ “Are there sufficient data points for each variable?” 
☐ “Are there sufficient data points for each time?” 








☐ Comprehensiveness: Taken together, the three operationalizations of complete 
data capture the entire construct of data completeness.   
If not, what other operationalizations should be included? 
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Operationalizations of Correct Data (Framework cells, page 11) 
Clarity: Which of the following are easy to interpret and understand? 
☐ “Is the distribution of values across patients plausible?” 
☐ “Is there concordance between variables?” 
☐ “Is the progression of data over time plausible?” 








Validity: Which of the following are representative of the construct of data correctness? 
☐ “Is the distribution of values across patients plausible?” 
☐ “Is there concordance between variables?” 
☐ “Is the progression of data over time plausible?” 








☐ Comprehensiveness: Taken together, the three operationalizations of correct data 
capture the entire construct of data correctness.   
If not, what other operationalizations should be included? 
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Operationalizations of Current Data (Framework cells, page 11) 
Clarity: Which of the following are easy to interpret and understand? 
☐ “Were all data recorded during the timeframe of interest?” 
☐ “Were variables recorded in the desired order?” 
☐ “Were data recorded with the desired regularity over time?” 








Validity: Which of the following are representative of the construct of data currency? 
☐ “Were all data recorded during the timeframe of interest?” 
☐ “Were variables recorded in the desired order?” 
☐ “Were data recorded with the desired regularity over time?” 








☐  Comprehensiveness: Taken together, the three operationalizations of current 
data capture the entire construct of data currency.   
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Recommendations for Complete Data Assessment (pages 13-15) 
Complete across Patients: “Are there sufficient data points for each patient?” 
☐ Clarity: The recommendation is easy to interpret and understand. 
☐ Feasibility: The implementation and execution of the recommendation would be 
manageable.  






Complete across Variables: “Are there sufficient data points for each variable?” 
☐ Clarity: The recommendation is easy to interpret and understand. 
☐ Feasibility: The implementation and execution of the recommendation would be 
manageable.  






Complete across Time: “Are there sufficient data points for each time?” 
☐ Clarity: The recommendation is easy to interpret and understand. 
☐ Feasibility: The implementation and execution of the recommendation would be 
manageable.  
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Recommendations for Correct Data Assessment (pages 16-19) 
Correct across Patients: “Is the distribution of values across patients plausible?” 
☐ Clarity: The recommendation is easy to interpret and understand. 
☐ Feasibility: The implementation and execution of the recommendation would be 
manageable.  






Correct across Variables: “Is there concordance between variables?” 
☐ Clarity: The recommendation is easy to interpret and understand. 
☐ Feasibility: The implementation and execution of the recommendation would be 
manageable.  






Correct across Time: “Is the progression of data over time plausible?” 
☐ Clarity: The recommendation is easy to interpret and understand. 
☐ Feasibility: The implementation and execution of the recommendation would be 
manageable.  
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Recommendations for Current Data Assessment (pages 20-22) 
Current across Patients: “Were all data recorded during the timeframe of interest?” 
☐ Clarity: The recommendation is easy to interpret and understand. 
☐ Feasibility: The implementation and execution of the recommendation would be 
manageable.  






Current across Variables: “Were variables recorded in the desired order?” 
☐ Clarity: The recommendation is easy to interpret and understand. 
☐ Feasibility: The implementation and execution of the recommendation would be 
manageable.  






Current across Time: “Were data recorded with the desired regularity over time?” 
☐ Clarity: The recommendation easy to interpret and understand. 
☐ Feasibility: The implementation and execution of the recommendation would be 
manageable.  
Do you have any suggestions to improve the recommendation? 
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Questions to Identify Scope (pages 5-9) 
 
☐ Clarity: The questions are easy to interpret, follow, and understand. 















☐ Usefulness: The questions are useful in identifying the scope of a research task 
and the relevant data quality assessment operationalizations and recommendations. 
Do you have any suggestions to improve the usefulness of the questions?  Alternatively, 
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Other Comments or Suggestions 
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